[
    {
        "start": 0.0,
        "text": "I'd like to thank the organizers for giving me the opportunity today to tell you a little bit about some of the work that we do in our group so we study obesity and as you might know obesity has become a global Health epidemic in the United States more than 66 percent of individuals are overweight and 33 percent are obese obesity affects more than a billion people worldwide and and accounts for 17 percent of the health care costs in this country and unfortunately we have a very poor understanding of a tediology and few effective Medical Treatments can combinate with this increase in obesity we're seeing an increase in obesity related metabolic complications such as diabetes dyslipidemia hypertension coronary artery disease and fatty liver disease but very interestingly not all obese people develop these complications and when they develop these complications they develop different ones unfortunately medically we treat these people the same diet and exercise which is highly ineffective and leads to high personal and medical costs and so critical that it's critical to define "
    },
    {
        "start": 62.039,
        "text": "the causes of obesity and complications to improve diagnosis care and reduce costs and as people gain weight they can deposit fat in their liver to cause non-alcoholic fatty liver disease and this can be in the form of steatosis which can progress to inflammation scarring and cancer and just like obesity this has increased over time to about 24 globally and then to measure this you can use histology but really um this isn't used clinically because it's so invasive and so many times it gets it gets picked up because people have elevations in a liver function test but these are not sensitive or specific for but generally that need to be followed up with imaging and because of this more and more of this has now been diagnosed and uh natural D has now become the number one cause of liver disease worldwide and like obesity we have no effective Medical Treatments making it now one of the most um uh unmet medical needs of our time and just like obesity only some people deposit fat in their liver so even bariatric patients only 90 percent of them deposit family liver 10 don't and "
    },
    {
        "start": 123.06,
        "text": "only a fraction of them go on to get liver disease and in work with we did individuals that have 30 fat in their liver 66 percent of the meat criteria for having the metabolic syndrome which is high triglycerides low hcls high abdominal obesity uh insulin resistance and hypertension and some of them go on to get cardiovascular disease but currently medically we have no idea who's going to deposit fat and get liver disease versus cardio metabolic disease and this is what we're interested in finding more about and to to study this we've taken a human genetic approach and both obesity and fatty liver are common genetic traits which means they're genetic variants that when combined with the environment predisposed disease and then we and others have helped establish that overall obesity by BMI abdominal obesity by waist to hip ratio and nafld by steatosis are horrible and can be studied in the population and the reason why we took a human genetic approach that I want to emphasize is that if you can identify genetic variants um that associate with a disease by definition they're causal and that's different than many other associations like money and power where you don't know which one cause one and the reason for that is your genome came before any "
    },
    {
        "start": 185.22,
        "text": "phenotype that you could have developed and this is very powerful because it allows you to use what you find to understand the susceptibility of a person to disease to Define uh the causal influence of that disease Define personal risk and develop Taylor Therapeutics for that disease and when we started this this was just a pipe dream and in fact the first three years of my postdoc nothing replicated in any of the studies that we did but eventually we were able to get reproducible associations and really one of the key factors to this was power and increasing sample size and over time we've been able to identify genetic variants these are Snips and associations with BMI shown here and you can see these very reproducible spikes coming off of of this which is a reproducible associations but to do this we really had to do a lot of development in terms of advancing genotyping platforms phenotype annotations and and harmonization genotype annotations and harmonizations qsync of data which I won't talk about but really this has been highly successful uh over the years "
    },
    {
        "start": 247.019,
        "text": "and now in our uh published and unpublished findings we have over 9 000 variants that associate with measures of obesity in over 400 that associated with liver function tests or fatty liver disease and one of the challenges as you heard previously is that when we find these associations sometimes they land in between genes and the other big challenge is actually most of the genes in the genome we don't really know how they work and so to get around one of these we helped develop one of these bioinformatic methods and the idea behind this is we might not know what a gene does but if it transcriptionally goes up and down with other genes that we know what they do now you can sort of put it in a biological context and so what tune and muda led is that they downloaded cell expression and tissue expression data sets and then they did principal components across those and then map Gene sets to those and then map genes to those and then what you can do is that you can drop anchor from your G was and look at the genes underneath it and then you can look to see if there's enrichment in particular tissues for those if particular Gene sets are "
    },
    {
        "start": 307.8,
        "text": "enriched in your associations and particular genes at different loci link up by being in the same gene set and this really dramatically increased our power to sort of see sort of connections between genes in our G wasses and when we applied this to our genome-wide Association analysis of BMI the nervous system really came out and as very significant and again we were expecting to hit the Krebs cycle but really we hit the nervous system and this was actually very very important because uh BMI has a stigma associated with it which is that it's all willpower but really the fact that we're able to map this is that it's biological and in fact we can map it to the nervous system which is really fantastic and then when we did it for abdominal obesity we got a more fact biology and when we did it for liver function tests most recently we can see the liver as well as the intestine pancreas and adrenal because these are as I told you not completely specific for the liver and then when we looked at Pathways that come out for BMI we could find uh highly enriched Pathways that affect polyphagia which is overeating energy metabolism "
    },
    {
        "start": 368.639,
        "text": "and neuronal biology when we did it for abdominal obesity we could find mesoderm development cell growth and survival Pathways and glucocorticoid receptor signaling and when we did it for liver function tests we can find lepro protein metabolism triglyceride metabolism and arachidonic metabolism and this likely represents a combination of non-alcoholic and fatty and alcoholic fatty liver in the population so this is really a pathway analysis that was not previously possible and the bioinformatics methods really allowed us to now hone in on some of these Pathways as being important and then uh they also allowed us to identify specific genes that could affect these processes so one of the genes in our common obesity um data set that we landed near was something called mc4r and this was actually previously known to be a monogenic obesity uh hit and then since that time uh they've developed mc4 agonists for the treatment of this rare genetic obesity and now this company is going to the population level and finding individuals that have common variants that associate with obesity and seeing if that drug would be effective "
    },
    {
        "start": 428.94,
        "text": "for them as well in addition to that we hit a lot of genes and in fact the majority of our genes we have no idea how they connect to obesity and fatty liver and one of those was like the calcitonin receptor at the time and really in work done by tune in combination with Martin Myers here they mapped uh different um different uh neurons in the dorsal vagal complex it can affect appetite and there's a particular kind of neuron that has the calcitonin receptor and when you stimulate this it actually causes appetite suppression so this is a new type of neuron and a new Target for obesity City that could potentially be better than some of the current targets which is gipr and glp-1 agonists that currently do suppress appetite but actually have a lot of side effects like nausea and hopefully these could be newer better targets for obesity and finally you know our first and best hit for um fatty liver disease is pmpla3 again a novel Gene that was now connected to this disease and really nice work done by Helen Hobbs she's shown that this is a gain of function that prevents sort of the release of triglycerides from these lipid droplets which somehow accumulate "
    },
    {
        "start": 490.5,
        "text": "and cause damage in in the liver and again this is now being targeted with Asos for the treatment of non-alcoholic fatty liver disease so really this work has led to actual treatments that are now in place for obesity and non-alcoholic fatty liver disease that are being tried uh but then as I told you you know the majority of the things that came out of these screens are totally novel so in our lab what we've done is we set up cell and mouse models and then we've uh knocked down and over expressed these genes and look to see whether they accumulate fat as well as look at other biochemical properties of altering these genes and we've also progressed to genome-wide associate genome-wide crispr screens to look for genes that may have not been picked up by g-was but certainly can affect these phenotypes and then are now adopting these high throughput high content screening to be able to do this to be able to find new pharmacologic and targeted treatments for these conditions going forward uh in in addition to that so we as I told you we carried out some of the largest genome-wide Association studies for liver disease uh and uh liver "
    },
    {
        "start": 552.24,
        "text": "function tests uh and then we look to see you know how many of these are actually fatty liver uh specific by Crossing them to an old data set that we had on Imaging and uh we did find that a fraction of them but only a fraction of them actually associated with non-alcoholic fatty liver disease and so there was still a great need to find more um you know variants that associate with non-alcoholic fatty liver disease specifically and so to do this we increased our sample size to be able uh to do this and so we assembled over 23 000 uh samples that had computer tomography measured fatty liver and then from the UK biobank we had um uh 43 000 MRIs available but we didn't have fat measures on these we only had 4 600 of uh with fat measures so what we did is we downloaded the the raw MRIs we segmented the liver and then we train a deep neural network resonant to be able to the measure the pdff which is the fat in the liver and then we trained in a certain portion of the samples and then tested it in the rest and uh we got it "
    },
    {
        "start": 613.56,
        "text": "to work very well with a correlation of 0.97 for reading these and then we applied it to read all 43 000 of these we then carried out genomide Association studies uh across these Imaging data sets and combined with Doctor diagnosed fatty liver disease and three other data sets uh with a fixed effects meta-analysis identified 17 independent variants and we used some of our algorithms to refine some of the hits here to ones that are specific for fatty liver and then we took these hits and then created polygenic risk scores which is to take the gene weighted by its effect size and look to see if we could identify individuals that are at high risk of having fatty liver disease cirrhosis or hepatocellular carcinoma in an independent data set which is the Michigan genomics initiative from here and what you can see is that these polygenic risk cores are able to identify 10 percent of individuals with an odds ratio of 2 and above five percent individuals with an odds ratio of greater than three and one percent of individuals with greater than four um uh Australia four for having these "
    },
    {
        "start": 674.16,
        "text": "diseases and really this is the best non-invasive biomarker of uh having a risk for these diseases that's currently available which is very exciting and much better than anything that we've had before and in work that I don't have time to show you we've also shown that these can predict incident disease which is new cirrhosis and then these provide uh information above and beyond these clinical markers so we're hoping that these can be implemented to better risk stratify individuals for better care in the future in addition to that we looked at how of these 17 uh Snips associated with multiple diagnosis and traits across the UK biobank and this is increase or decrease of these and uh basically by cayman's clustering that they fell into seven different groups and then again we made polygenic risk scores from these and then looked to see how they affected multiple human traits and what you can see here is that um all of them affects theatosis because that's our study was biased for that and but then some of them increased cirrhosis risk and some of them don't affect it some of them "
    },
    {
        "start": 734.519,
        "text": "increase serum triglycerides and and lipid rates and increase your risk of heart attack and some uh sort of decrease it and some increases some increased diabetes and body mass index whereas other ones decrease it and really what you see here is that seven different patterns of these seven metabolic subtypes and these actually don't uh all match the epidemiology right now of fatty liver disease which has this pattern here and the reason why this is important is this comes back back to the idea is that epidemiology lumps everybody together but it's highly unaccurate and as I told you not all obese people develop complications and then not all people the deposit fat in their liver and get complications and so what this now allows us to do is now we have biomarkers for these sub uh phenotypes these metabolic diseases and not only do we have biomarkers to identify these subtypes but we can match them back to targets for therapeutic intervention and you can see that depending on the target so if you have uh for example if you want to Target pmpla3 to decrease fat you're going to "
    },
    {
        "start": 795.06,
        "text": "increase sort of your heart risk and if you happen to unfortunately apply this drug to these people you're actually going to increase their side effects from this medication because they're already predisposed to heart disease so really this can help you to find the individual and mash them to the right drug in addition to that when you look at these they fall into nice uh new uh Pathways and some of these like pmpla3 with its other members of uh cause a fatty liver by decreasing lipoprotein output some cause it by increasing lipoprotein input to the liver to cause fatty liver some increased risk of diabetes and insulin resistance peripherally and maybe by increasing fatty acid release to the liver increased fatty liver some may affect insulin signaling in the liver to promote fatty acid synthesis including by taking glucose and making it into fatty acids and some may function by actually not allowing triglyceride to exit the liver and diverting it to other kinds of phospholipids that can cause fatty liver disease so this gives us new insights "
    },
    {
        "start": 855.48,
        "text": "into the pathophysiology of the disease and in fact they can now better link these to ongoing treatment trials like the Asos or pmpla3 to certain thyroid agonists that affect lipoprotein buildup to Asos that decrease triglycerides to diabetes specific and mttp specific treatments and then specific treatments for de noval epigenesis depending on the pathogenic mechanism that the patient's really suffering from and finally we are taking this to the clinic and um here um what we what you see is that a few years ago we found that insulin resistance multiplicatively interacts with pmpla3 to promote fatty liver disease so if you have a high risk genotype and high insulin you have greater than a 90 chance of getting fatty liver low risk genotype and low insulin resistance 20 percent and the people that are at highest risk genetically actually benefit more from decreasing their insulin resistance so we're actually recruiting from the Michigan genomics initiative and putting them on keto "
    },
    {
        "start": 916.98,
        "text": "diets and we're measuring how much fat accumulates in these individuals with the assumption that these guys are going to benefit more than the people that are at low risk and again you can see how we can take these genetic information and then use it to personalize treatment for future sure so basically I hope I've shown you how we can use human genetics to define a disease causes and guide Precision treatment we can use population science to Define causal genetic variants and environmental precipitants we can use integrative science to Define causal genes Pathways tissues disease subtypes and tissue targets and side effects functional science to test these targets and Define mechanism and develop assays for development of treatments and clinical science for risk stratification and genetically based diseases and really I think we've come a very long way in the 10 years as I just shown you and I see a very bright future with therapies that in the future based on this work will be more effective with your side effects so I'd like to thank our participants many of the consortia that gave data for these work I'd like to thank the gold Consortium for the "
    },
    {
        "start": 977.16,
        "text": "fatty liver work especially Nicole all right who co-leads this with me members of our laboratory and our funding and I'd really like to thank Gil Brian and my colleagues in dcmb that have provided a wonderful home to do this work over the last 10 years Happy 10 anniversary and many more to come thank you [Applause] "
    },
    {
        "start": 1049.78,
        "text": "yeah so um our original plan was to have a 15-minute sort of q a to invite the speakers back up and just have a panel discussion um it turns out we're about 15 minutes behind the schedule so I think instead we're gonna go straight to break I would encourage you if you have questions about individual talks to um to approach the speakers and and ask them during the break um and uh we'll reconvene here in about 15 minutes and maybe think the speakers one more time okay um okay yeah hi Kurt I'm so sorry I didn't show up earlier okay um it was yeah yeah yeah it is what it is okay so "
    },
    {
        "start": 1115.46,
        "text": "100 I did it through here we did we did it through the video conference sure right and we called in so we did a video conference we dialed my address yeah went and then I think I went two stores and I went video Too part of me so can we connect to the zoom here is this your account um I'm not on Zoom here that's not how I was thrown to do it by the previous person when I had a wonderful of like us okay I have [Music] nothing "
    },
    {
        "start": 1178.76,
        "text": "thank you thank you yeah "
    },
    {
        "start": 1245.419,
        "text": "I feel like foreign "
    },
    {
        "start": 1320.24,
        "text": "thank you yeah Instagram "
    },
    {
        "start": 1390.08,
        "text": "thank you foreign "
    },
    {
        "start": 1458.26,
        "text": "thank you so awesome I don't think "
    },
    {
        "start": 1528.64,
        "text": "all right oh my God "
    },
    {
        "start": 1589.72,
        "text": "a good day so expensive thank you so far "
    },
    {
        "start": 1697.7,
        "text": "foreign "
    },
    {
        "start": 1766.059,
        "text": "all right okay foreign "
    },
    {
        "start": 1853.84,
        "text": "thank you you probably foreign "
    },
    {
        "start": 1918.46,
        "text": "all right I do too okay okay foreign "
    },
    {
        "start": 1985.34,
        "text": "foreign thank you "
    },
    {
        "start": 2060.159,
        "text": "foreign are you coming yeah come here now because I don't want to be the one in charge of being late I'll wait for Maureen so this is a special moment of Pride for us uh we usually give the student awards during the retreat "
    },
    {
        "start": 2120.82,
        "text": "these are departmental Awards and we have three different kind of awards so I think Maureen is starting yeah that's so I'm going to be presenting the bioinformatics student service award this year um so this year I think it was a no-brainer identifying who would get the service award uh we're giving it to two students so back when we became a department there were not any student-led groups it's been wonderful to see over the years several student groups formed so this award this year is going to seduce to the two students who started our bioinformatics graduate student Association or bgsa and not only were these did these students start this during the pandemic nonetheless but they were also involved with other activities as well um like dang and the Pips recruitment so "
    },
    {
        "start": 2181.359,
        "text": "this award goes to uh Ford Hanna and Kathy Smith if you can come up get your award [Applause] we're supposed to pause for a picture is Ford here oh okay uh the next student award and I believe the overd is just for the audience are not aware of who they are is for the academic achievement award which we typically give to a student who after their second year passed prelims without any conditions and has a 4.0 GPA and when there are several contenders which has happened most of the years so far "
    },
    {
        "start": 2243.18,
        "text": "then uh those who took the particularly hard courses this year the ORD is ufang Zhang I don't know if she's here and as she is she's continuing a strong come here please she's continuing a very strong a strong tradition that was started by our next speaker in fact um so uh we are which is she came to us from biostat Department uh and turn it around and so she has taken very heavy biostat classes um and past prelims without any uh conditions and so the third award is newer for our program we are very pleased and very "
    },
    {
        "start": 2304.54,
        "text": "proud to recognize uh Master students for their academic achievement and uh this year we had two people so we basically could not decide and they're both equally deserving so we uh this year the award goes to uh two people the first uh person is then grew with PSI then gray are you here [Applause] Right congratulations thank you and the second award those two uh uh ji Jun you no no "
    },
    {
        "start": 2366.099,
        "text": "no here [Applause] you want a picture of all of the awardees that are here and us great congratulations for your great achievements and great service for the program and hopefully Ford and jiajang will get their Awards uh at some point yeah yeah thank you so the next uh two talks I have a great pleasure as graduate chair uh director of the bioinformatics "
    },
    {
        "start": 2428.619,
        "text": "program our first speaker is one of our very very first class uh that graduated in 2006 Daniel Rhodes who came to us actually initially also wanting to study medicine but he then quickly decided that uh research is much more exciting he worked with arul chanayan and then founded a company with him and switched between companies and I think he will talk more about uh that's so Daniel take it from here foreign [Music] to be here congratulations uh to the to the department on 10-year anniversary congrat uh congratulations to Brian to Gill and all the faculty and the students uh you're part of something special here when uh Brian asked me to speak "
    },
    {
        "start": 2488.68,
        "text": "um it kind of took me down memory lane he asked me to talk about my time here uh in the bioinformatics program and and the career Journey that I've had since so it's a real pleasure um to do that with you uh today so the title of my talk and it's hard to believe is reflecting on 20 years in bioinformatics it was about 20 years ago today that I joined the program the bioinformatics program and so I'll give you a little bit of uh Insight so see here there we go okay so three themes for today the first is gratitude uh a huge thank you to the leaders of this program and and for the opportunity to be one of the first graduate students this this experience kind of set me on my journey um and it has really been a continuous theme from actually the first projects I did 20 years ago to what I'm doing today I'm not saying that that's a rule and you all have to continue to work on what you're working on in your into your Graduate Studies for 20 years but it "
    },
    {
        "start": 2548.98,
        "text": "happened to work that way for me so a big thank you um to to the program the leadership of the program what I'm going to do in my talk is take you through a few stories um so I was kind of looking back I've got a few chapters in my career starting with my time in the program and my hope is uh to leave you with a few Lessons Learned especially for uh the students who are in the thick of it right now um to to think about um you know how you might best spend your time what things you might focus on what perspective you might bring um to your work so I hope you I can I can leave you with um to have some valuable Lessons Learned so let's start with uh stories and so chapter one of my story in bioinformatics is uh the University of Michigan bioinformatics program so as um as was just alluded to I came to the program um as a uh mstp student actually before I was at mstp student I was just a medical student um very proud to be a medical student at the University of Michigan but I found out quickly that I really wasn't in love with the idea of practicing medicine I "
    },
    {
        "start": 2611.44,
        "text": "loved the science I loved the problems but but didn't love the idea of practicing medicine and I admire those who do all of my former classmates lots of them I keep in touch with but I've kind of found it really just wasn't for me but at this time sort of late 90s early 2000s you know we've got the human genome and now we've got a technology which is now like this old time technology DNA micro race and we're beginning to generate for the first times enormous amounts of data we didn't call it Big Data back then we didn't really have that term but but for me this Prospect of using something that I always felt gifted at mathematics and uh you know the big data and and and genomics to unravel complex human disease was just kind of the coolest thing that that I could imagine working on um and and so kind of the first kind of lesson learned for me is uh this was like big light bulbs going off like intersection of what I'm good at um what's really interesting to me and what matters to society and so with "
    },
    {
        "start": 2671.98,
        "text": "those things coming together I really felt like I found my calling and and passion and so I would encourage each of you you know when you're thinking about um the work you're doing make sure you find work that lines up with your passion don't don't get trapped in kind of incremental projects that or a space that you're just not that interested in even if it sets you back even if it puts you behind find the area that you're passionate about so like I said I transitioned from medical school to the medical scientist training program um this was sort of my kind of half step out of medicine um I'll tell you in a bit how I ended up taking the full step out of medicine but joined the bioinformatics program and um was just just so fortunate to um meet and and then study with Dr rule chanayan who of course now is one of the greatest cancer genome scientists on the planet and has just had seminal contributions way back when I was a Rule's first graduate student he had just published a nature paper on prostate cancer genomics I had read that "
    },
    {
        "start": 2734.26,
        "text": "paper with great interest and sort of knew right then if I like this guy this is who I was going to train with like because he was you know just doing incredible work my first meeting with rule having had some experience coding and doing mathematics and telling a rule you know I don't really think I'm going to be that good in the laboratory but but you know this data problem is something that's for me um in that first meeting when I was you know just considering working with him he said to me you know what if we tried to put together all of the world's published cancer genomic information what could we do with that and and I laughed thinking oh wow I mean this this is like a dream come true like uh this I I could not only Advance the field and Advance our scientific understanding of of cancer um but also could could build something that had had impact and so it was that first meeting that um set me on my journey with a rule and I remember thinking I like this guy because he thinks big a rule it is not an "
    },
    {
        "start": 2794.68,
        "text": "incrementalist he's looking for the next big uh challenge the next big opportunity to advance research so so I've kept that kind of feeling I had after that first meeting with me for my whole career like think big let's do things that that really matter so as a graduate student now having committed to a rules lab and um you know to the bioinformatics program finishing those first years of medical school which were somewhat painful for me but then moving into Graduate Studies um I I found that this was like kind of the most incredible opportunity you could imagine you're your only real job as a graduate student is to dive as deep as you can into a domain into a space and become a true expert and then look for opportunities to make an original contribution yourself and and so I I did that and I loved it because I had found an area that I was passionate about I consumed everything and so when I have time I still do today sometimes I rely on some of the folks on my team to do the consuming and then share with me but "
    },
    {
        "start": 2854.8,
        "text": "back as a student I consumed everything I read every paper that was relevant to our space then just read the papers I read every detail of all of the supplementary information and I studied it so that I truly understood the work that that author had done to deliver their scientific impact I think too often student events take a light look at others work and don't go all the way in and I would encourage you go deep study the supplementary information for the for the for the leaders in your field for the great work um that they've done and published make sure you know it almost as well as they do because then you can take the next leap so and you can you only ever be able to do this in your career as a graduate student As you move into your career into faculty positions or into industry you'll never have the time and space that you do as a graduate student so take advantage of it and use that time okay so in a rules group we did incredible "
    },
    {
        "start": 2915.88,
        "text": "work on cancer genomic data but but we also said let's not just do let's not just do bioinformatics for ourselves let's build something so we we built a cancer genomic database and web application called oncomine so that that challenge that Grand Challenge that a rule gave me at the beginning what if we could assemble all the world's published cancer genomic uh information um we we did that and we built we didn't just do research we built a product really to enable our research but equally importantly to enable the research of others so when I think back to that work in you know building on command um yeah I learned how to build data models how to build data curation pipelines how to build data analysis pipelines statistics and then also how to build software I didn't do all that work myself we had a team but I learned how to go from a concept and data to product and so this is another thing that this isn't going to be right for for everyone but but I would say when "
    },
    {
        "start": 2975.88,
        "text": "you have the opportunity don't just do bioinformatics for your own research to the extent you can build something and share it with the world because if you can you'll just absolutely amplify the impact of your work and that's that's what we were able to do with oncoming now a rule is well-resourced laboratory right so I can't say that I I can't take that for granted so so when we were building on command with Scientists I.T folks database administrators web application developers and data curators all as part of the team and so that's another thing I learned as a graduate student is you can't do it all alone you really need to to find others who have skill sets that you don't have and bring together a team around a common cause and that experience I had building that oncoming team is something that really carried through to to my career in in building companies um and so it really as as Bo said it really is all about the team the team the team so with that ankle mine experience we we grew that application "
    },
    {
        "start": 3038.04,
        "text": "to ultimately have tens of thousands of users globally um I always had an entrepreneurial bent I always wanted to build a company um even from early days in my PhD and and so we um connected early on with the office of Technology transfer so this is another just point to make if you if you're doing work that's leading to new software applications or new intellectual property around Diagnostics or Therapeutics we have an incredible office of Technology transfer here at the University of Michigan and they will partner with you shoulder to shoulder to understand the novelty of your work and to file patents to file copyrights and trademarks and the like so so we did that in the early days of oncoming we said hey we're going to make this resource available to all academic researchers free of charge for not-for-profit research but we're going to require Pharma companies to license access through the University of Michigan and this brought in funding for the laboratory and all also showed us that we really had a business opportunity here and so we I was able to "
    },
    {
        "start": 3098.04,
        "text": "lean on the office of Technology transfer Rule and I were to advance this ultimately to what became chapter two for me which is which is spinning this work out in in creating a company around it I would be remiss if I didn't look back and think about uh using the oncoming database together with Scott tomlin's and a rule to pardon yeah well I think we're just going to go right to chapter two three four Brian thank you um this is the fun part anyways uh so um we discovered Gene fusions from the database and then went on and won the aacr team science award um from that so it's something we're all I'm quite proud of after Michigan we spun that work off and I transitioned from graduate student to CEO very interesting transition uh you know expert in the in the data in the application but really knowing nothing about building a business um my advice to anyone who has that entrepreneurial event is take advantage of this incredible Community we have in Ann Arbor Tech transfer Ann Arbor spark "
    },
    {
        "start": 3158.88,
        "text": "and all sorts of programming inside the University of Michigan fast forward medical Innovation M-Track program the Michigan biomedical fund you have this incredible Community just waiting for brilliant students and faculty to take their technology out and create companies around it and they're really waiting to help you do that uh so we were able to do that with compendia and build a really um incredible company a company was acquired this is a process as well and so moving from compendia small startup that was my thesis work to a Fortune 100 company and Thermo Fisher Scientific incredible opportunity to build Diagnostics and Lead teams and this is really where I learned how to truly lead teams and how to be a leader in an organization incredible mentors and just really emphasize for me the importance of of leadership we did a lot of great work there ultimately that kind of moved moved my work out of the kind of theoretical data domain and into the physical world of Diagnostics and delivering real value to patients which "
    },
    {
        "start": 3220.859,
        "text": "is which has really been Central to uh to to my personal mission and and what I'm working on and delivering so that leads me to where I am now so this is my second company called strad oncology um uh where I'm the CEO where Precision oncology company we're sequencing tumor genomes and transcriptomes to drive personalized treatment and we're really trying to take the next leap Beyond tumor mutations and into multivariate DNA and RNA predictive biomarkers for cancer Therapeutics it's been an incredible experience with Incredible co-founders and investors and and now delivering on um on on on what we think is a really big Vision so this is this is kind of last lesson learned is um this idea of visioning it works create a vision for yourself for the work that you're doing for your team and and and and really try to detail that clearly and you can really make kind of anything you dream up come true is is my is my real belief all right so gratitude stories Lessons Learned I've got the "
    },
    {
        "start": 3281.46,
        "text": "list there this is what I took from being a graduate student and my career path I hope it was helpful um to the students here special thanks to um uh those listed and I'll uh I'll stop there thank you wow thank you I for this Inspire inspiration for students you were I don't think you were there in the in the lunch one with students there were several students talking about entrepreneurship so uh those who asked please uh go to see Daniel who seems to have had a lot of success and a lot of experience the second student uh Alum from the program to introduce is Aaron Shellman who uh was there during the lunch and had uh already I I kept forgetting to count how many different companies but "
    },
    {
        "start": 3341.46,
        "text": "she's going to talk about that Aaron graduated in 2012 so exactly 10 years ago and as far as I could tell she is the only student who graduated from Chuck Brown's lab so if anyone in bioinformatics is interested in uh check brand has lots of students but rare bioinformatics the first yeah the the own service and only bioinformatics tool she also she also started a trend that you heard about earlier she came to us from biostatistics and that trend has continued every year we had one or two students from biostatistics choosing bioinformatics because we are more applied and they're more interested in the applications than in the uh about so I don't want to take more of your time Aaron uh it's a pleasure to have you here thank you [Applause] yes hi thanks for that introduction uh and I "
    },
    {
        "start": 3402.96,
        "text": "really want to thank Brian for the invitation to come back to Ann Arbor and participate in the the celebration of the 10-year anniversary of the department uh it's it's quite an honor and it's been a real pleasure of just walking around and seeing seeing our old neighborhoods um this is a little bit unusual for me I usually give technical talks um but today I want to step back a little bit and take some stock and share a little bit more about my journey and in particular in my background and how I got here but I also want to highlight how this department really uh nurtured my my interests uh coming in and developed the the skills that have been um really critical for uh my my career let's see so I don't want to get yelled at by Brian I don't know if you see him up here like police in the time so I think I'm just going to skip this this was going to be my in a nutshell but I'm going to dig into the details anyhow so for the sake of time I'm gonna move on um from the overview and actually take "
    },
    {
        "start": 3463.14,
        "text": "you back if you can imagine a little more than 10 years ago um the version of me uh at Case Western Reserve University in Cleveland before I came to the University of Michigan I was a young economics major and um I was always really interested in quantitative ways to describe human behavior and in particular I was interested in this field of Behavioral economics which combines psychology with economics and really seeks to explain why it is that uh weird humans tend to act really differently in reality than what we would expect using classical models and if you know anything also about Case Western it might not come as a huge surprise that at the time I was also really interested in computers and I included this this Relic here for the for those of you too young to remember what life was like before you could carry computers around in your pocket and in your backpack they used to be pretty stationary and and this is actually a pretty Sleek one uh in "
    },
    {
        "start": 3524.22,
        "text": "comparison to how they how they sometimes looked so this is pretty early internet days but I was already kind of developing this interest and using inner the internet and computer technology to ask research questions and to collect and analyze data and so I spent a lot of time in my senior year doing my honors thesis in scraping data from eBay and doing online surveys building those because it was very actually kind of difficult to do at the time to explore differences in risk perception and risk conversion across genders and so very uh interested in this area and actually economics was my launching off point in my introduction to biology and specifically through the study of Game Theory where I was introduced to this book evolution in the theory of games and this was my Gateway into ecology into evolutionary biology and as soon as I realized that I could you know use and translate what I had been learning the models and the quantitative approaches that I had been learning in economics and then apply "
    },
    {
        "start": 3584.339,
        "text": "those to this for me kind of new field in in biology I was really hooked on that and I quickly added evolutionary biology degree to my studies and then I had the really good fortune between my the summer between my Junior and senior years of getting an internship at the National Institutes of Health in the division of computational biosciences and that was my first exposure to machine learning which is looks really different than it does now uh but that's what really cemented for me that this was the area that I wanted to be at this intersection of quantitative sciences and statistics machine learning Computer Sciences and then most importantly um the biological sciences and so I uh continued uh and extended my love of research here at Michigan First in the biostatistics Department like Margaret said uh and then in the bioinformatics uh program and as a member of the Brant lab I was exposed to a lot of different data sets and "
    },
    {
        "start": 3645.42,
        "text": "research projects that were being led by investigators who were using his metabolomics core lab and doing analysis on that wide variety of topics and research projects gave me just this incredible quantitative Foundation which was really the basis of my career especially uh early in my career when I was doing a lot of technical work still I got a lot of really good practice in developing efficient analysis workflows and making compelling visualizations that tells stories with data uh and presenting results and and overall just learning how to be an effective collaborator um on other people's research and those things are still skills and and techniques that I use every day in my work and then in my thesis work kind of like what I was doing uh in my thesis workout case uh I again took inspiration from the high scale algorithms and approaches that were powering the web at the time um things like Google's pagerank but "
    },
    {
        "start": 3705.72,
        "text": "instead of mining hyperlinks or social networks I was applying these algorithms and these approaches to metabolic networks and Mining those for structural properties that I could correlate with physiological function I even use those Network properties to explore evolutionary relationships and proposed a metabolism-centric way of measuring organism similarity somehow remembered that uh so after graduating then with my PhD in bioinformatics I moved out to Seattle Washington and I did what all young aspiring bioinformaticians do which is immediately get a data science job in Fashion retail thanks thanks for that uh so I started my career uh as a data scientist in the Nordstrom data lab and we called it a lab so it's legit um this was a this was a period of really enormous growth for me and it was actually a really ideal place for me to start my career data lab was kind of a "
    },
    {
        "start": 3766.68,
        "text": "special team it was this interdisciplinary group that was split between these super experienced really seasoned software engineers and then these somewhat less seasoned less experienced data scientists like myself and this is really the team where I cut my teeth and I learned how to write and ship code that millions of customers on nordstrom.com could actually rely on working and this is where I grew my ability to work collaboratively on a team and appreciate and grow my depth and tools to help me work on joint code bases and have higher standards of practice um and my specialization was recommendation algorithms and personalization so thematically again I found myself working with behavioral data from the web behavioral and preference data and so at the time that I was learning a lot about engineering I was actually showing off a lot of the scientific skill set that I developed here in this bioinformatics department including obviously the visualization skills of a "
    },
    {
        "start": 3828.42,
        "text": "highly seasoned phylogeneticist I I think um one of the projects that I'm the most proud of is actually what some of these these images I was able to dig up are from and it involved creating an outfit Builder uh that required a lot of creativity and quantitative reasoning and and actually empiricism so our goal here was to create a really compelling recommender to help people build and style outfits based on an initial seed product so maybe a shirt or a pair of pants that they've already selected so color is obviously a really critical piece of styling and we had a ton of really granular data about garment colors from from these photos from the catalog but the question was how do we teach algorithms to reason about colors and to make stylistic and realistic choices well one of the approach you might imagine is just use color theory so we know quite a lot about primary colors secondary colors but it turned out that that purely kind of theoretical approach didn't produce really realistic Styles like you and I would pick out for "
    },
    {
        "start": 3889.98,
        "text": "some of us would pick up for for ourselves uh so instead of a color theory approach I I took an empirical approach to this problem I realized look we have all of these actually amazing domain experts called fashion designers who make these really good decisions about how to combine colors all the time so why don't we just learn from them and then feed that to the algorithms so when something like this we mind every product in our catalog to derive what we call complementary color sets by extracting all of the Colors that appear together in the same garment so you can kind of see that example from that dress up there you've got four kind of colors those two shades of blue and the black and a gray and together those Come Those work together to create the pattern that you see then we looked across all of those sets and we Quantified the frequency at which those colors co-occurred within garments and then to make recommendations all we had to do was apply some simple logic "
    },
    {
        "start": 3951.66,
        "text": "like match this with a contrasting color from the set of commonly co-occurring colors and we could find contrasting colors you know how do you how do you explain what a contrasting color is then to an algorithm you can do that by using things like distances in the RGB color space very similarly to how you might navigate evolutionary distances in bioinformatics so this is a great example of me taking a lot of the approaches that I was using and applying them to a super super different setting than where I had learned them this approach sort of empirical approach uh led to a lot more realistic Styles and also meant that our algorithms uh evolved over time as the data continued to update the models they reflected seasonal Styles and Trends which was a little bit of a benefit that we really hadn't anticipated initially and so we were teaching them to think the way that our designers think okay okay see uh so okay let's talk about where I "
    },
    {
        "start": 4013.339,
        "text": "am now though uh so this is this is just a short transition slide really to help make the conceptual links so coming from a really different area back into where I am now as a leader of the data science and data engineering organization at Ginkgo biowork so synthetic biology company you might think wow that seems really different the reality is it's not all that different and actually a big piece of what we do in this space is also create recommendations so conceptually what all you're doing there is taking a big search base and trying to compose it down to relevant results and that's actually one of the first things um that I did at zymergin very related to now what I do at Ginkgo bioworks which is where I am now so today I lead the organ the data organization there at Ginkgo which is a leading synthetic biology uh platform synthetic biology in my view is the ultimate industry for people like us who have sort of an engineering mindset and who love working across disciplines and "
    },
    {
        "start": 4073.46,
        "text": "it combines the latest Technologies and genome editing robotic automation High throughput screening machine learning and data science brings them together in what we call bio foundries that engineer cells to make materials and molecules for a range of applications so at Ginkgo we work with customers in agriculture flavors and fragrances food science waste remediation and even in the production of cannabinoids so this practice of synthetic biology is really organized around the design build and test or dbtl cycle I'm curious is anybody you guys familiar with this concept the dbtl cycle okay uh well this is something you're if you if you are in the space you'll you'll definitely learn like the back of your hand um the dbtl cycle is really for Rapid experimentation and iteration to an engineered cell that performs to a predefined specification so usually some combination of yield and productivity of a molecule of Interest so in the design phase we're using computational methods to identify targets for genetic "
    },
    {
        "start": 4134.06,
        "text": "engineering and sometimes using there's also to optimize sequence so those might be through mechanistic techniques that maybe you've used like flux balance analysis or those can be kind of Black Box models from machine learning or they can be combinations of those powerful approaches in the build phase is where we're actually building the genetic constructs and transforming the cells so that they express the new engineered inserts uh and then in the test phase we screen the candidates at high throughput and we generate large volumes of data that describe the performance of those cells and making the products of Interest incidentally as a statistician this is one of my favorite Parts because this is where a lot of the classical techniques really come to the fore so a big emphasis on design of experiment on hypothesis testing on things like normalization to try to mitigate batch and process effects from the measurement data and then the learn step is all about synthesis synthesizing the results from those multiple rounds of experimentation uh and screening to inform the next "
    },
    {
        "start": 4195.8,
        "text": "design step but then also to bring up the level of abstraction to another level to another layer so that we can learn about biological properties that we can actually move into a different context move into maybe a different host cell or a different Target molecule basically teach ourselves to be better Engineers of biology so that's me in a nutshell before Brian kills me he wanted me to talk a little bit about the modern workplace and what's changing for us and what's important about the skills of today um to be successful and it's undeniable obviously that the pandemic has changed a ton about the way that we live uh and we and work and we couldn't have anticipated that 10 years ago um but I'm happy to say that this department really prepared me for that rapid evolution and first and foremost if you took anything from my career journey I hope it's the realization that like this department and the people in it and the programs modern problems are super interdisciplinary uh no matter whether "
    },
    {
        "start": 4259.04,
        "text": "you're in uh you know Fashion retail or you're in synthetic biology you're going to be tasked with these really thorny problems to solve uh and sometimes those are very high scale problems internet scale problems and your ability to successfully find Solutions is really going to hinge on how much exposure you've had to different ways of thinking and solving problems and then your ability to pluck them out of one context and translate them to where you are to the problem that you're facing the other big thing uh for me is synthesis of information from all kinds of heterogeneous sources so when I think about the types of things my team does and the data they're using like thinking about a process like normalization trying to eliminate batch effects that might include data from like operations data from liquid handlers how long was this plate sitting on the platform before it was actually acid and then you have the measurement values themselves coming from the assay and then you might also fold in bioinformatic context that actually describes what those engineering what what was the goal uh what was the biological context around what you were "
    },
    {
        "start": 4320.96,
        "text": "engineering that we can actually use to translate what we discover to other settings and become better biological engineers so it's really about knowing as many disciplines knowing the thinking of disciplines um as you can and then synthesizing disparate information how am I doing Brian okay uh good so the other the other piece of this is of course a lot of us are purely computational scientists I know that that I am and so maybe the most obvious change um in in the modern workplace is the move to remote work um I let a distributed team actually prior to the pandemic as I'm origin and so that prepared me really well I think for leading a remote and distributed team again at Ginkgo and to me the the I get asked this a lot what are the keys to success in this space and I actually don't think it's that special or it's not that different from the keys to success without without remote work to me it really comes down to outcomes and "
    },
    {
        "start": 4383.179,
        "text": "expectations so outcomes it's all about being intentional and what you're trying to get out of every interaction or or even with your work how do you know when it's done what's the level of performance that's required to solve this application ship it and move on to the next thing be intentional and know that before you start similarly for communications what do I want to learn from this interaction what do I want in for leaders what do I want my team to come away understanding after this discussion and knowing that going in seems obvious but it's it's a skill that I think we have to get better at likewise expectation setting is really important we're working across different time zones uh we we really it's I think more important than ever to be super communicative and transparent about the settings that make you successful or not successful how do you want to work when are you going to be working when are you not working and being explicit about those boundaries I think are really critical for this this crazy era that we're in and then finally the most important thing I think is having great advocates "
    },
    {
        "start": 4444.14,
        "text": "in your corner I feel really fortunate to have always uh had Brian in Chuck uh in my corner uh through through grad school and then that has continued for me throughout my career so again thank you both uh for being there for me and for inviting thank you guys I'm so proud of each and everyone and you know Dan was at the big boss for the uh Department yeah you know and I have a picture of you over there how wonderful people you are feeling bad "
    },
    {
        "start": 4504.739,
        "text": "just coming back because uh you know what it's like the program but thanks so much and congratulations will find our new students to pick up their Awards but everyone should be so proud look at what could happen you don't have very much thank you so it's time for a very very special uh you know we did have a child is there during covet and then we picked up one uh and uh and now we're uh here for our eight Bowman lecture speaking out the event for um "
    },
    {
        "start": 4568.42,
        "text": "your threat called generously with us thank you Brian thank you all for being here and those on Zoom hope you're enjoying the whole day this is a very special tree we have sort of a renaissance man of science called him Thorpe he's fine what's already a quite remarkable tradition of these uh annual except for two years of covet annual homemade lectures and for those of you who may have been at all of them or some of them are none I thought I'd just show you quickly who the predecessors are so Leroy Hood Zach kohani but his Institute for assistance biology in Seattle exactly Harvard and David Shaw from Shaw research d e sharp very remarkable chemist and then George post who's in Arizona "
    },
    {
        "start": 4630.38,
        "text": "a tool Butte UCSF ogatory and skya whose Department I visited at Princeton yesterday and now unless in June at our Retreat Brad Malin and now Holden Thorpe so we're very very proud of everyone and we think we've established a great tradition here and uh sure that Holden appreciates that as much as we do well I don't need to read to you what's already beautifully described here in biosketch for Holden just to say that is world-class chemist grew up in a small town of Fayetteville North Carolina I learned from his parents who was inspired by his parents to be greatly interested in music and theater and the Arts went to a University of North Carolina Chapel Hill "
    },
    {
        "start": 4691.04,
        "text": "and then he did a five-year PhD program at Caltech in three years Harry gray and then he did a postdoc at Yale in about a year apparently and then he returned to North Carolina for a faculty position and soon became uh I think chairman of chemistry but in any case the dean of arts and sciences and from that at a very early age became the chancellor which is like the president of the University of North Carolina Chapel Hill within the North Carolina upper higher education system so that was quite a rapid and remarkable and much appreciated early career and after some turmoil which I think he probably had no part at all except to shake his head with the athletic department he relocated to a position as a Provost at Washington University in St "
    },
    {
        "start": 4753.14,
        "text": "Louis and after six years there he was recruited to be the new editor-in-chief of our most distinguished set of journals Science magazine and now the family of Science magazine journals so uh I that reflects my hat as Once Upon a Time president chairman of the board of the aaas so welcome at Holden we're very pleased that you were even so invested with our students and the faculty today and we're all eager to hear your remarks by the way I expect you know from the title you already heard it has a lot of policy content he's also published two books which are mentioned here in the text of his friend Buck Goldstein you'll find the titleism pretty exciting welcome thanks Gail thanks everybody and congratulations to your department on 10 years what an exciting "
    },
    {
        "start": 4813.38,
        "text": "um day it is for you and what an honor uh it is for me to be among these uh distinguished folks who have given this lecture uh this will be the well first Gill thank you for everything you've done for the aaas I agree with you that um the science family are the most distinguished journals in the world but I've seen a lot of instances of the word nature up here today so I just want to make sure everybody knows where to find me um because you know as Gil said uh you should think of us first we still might reject your paper but you should still think of us first um no it's listen uh if you get to be the editor-in-chief of science it's just one of the uh truly extraordinary opportunities for a scientist and I'm I'm so fortunate to be able to do it and I appreciate Gil and his intro mentioning the fact that there was "
    },
    {
        "start": 4874.219,
        "text": "turmoil at the University of North Carolina I hate it when people say oh and then he was the chancellor and then he was the Provost and like the students are going oh I guess everything went perfectly in his life uh and that's not a very good educational message uh because even though I had this meteoric rise in my career I got absolutely destroyed at the University of North Carolina when I was a chapel at when I was a Chancellor um by a combination of politics and and Intercollegiate Athletics and uh inexperience and so it's just a reminder that when you hear these intros of people a lot of times the the hard Parts get left out and no one who gets a glowing introduction really has that story so that's an important thing for for students to to hear and I really enjoyed interacting with you all uh earlier today so uh this will be the least technical talk you've heard um because I'm not I don't do experiments anymore I don't have a lab anymore "
    },
    {
        "start": 4935.84,
        "text": "um what I do is uh observe the behavior of scientists uh and so my predecessor Jeremy Berg like to refer uh to us as um sociologists of Science and so that's what I'm going to tell you about uh today um and I have another great colleague who's our executive editor now and runs Life Sciences for us valda Vincent she she refers to what we do as being the people who work backstage um you all when you publish with us you're the people that are on the stage we're the people that are making sure you have your props and that the lights work and that the orchestra sounds good and as Gil said I grew up in the theater so that metaphor really really works for me uh quite a lot but what I want to do today is talk to you about all of these trends that we have in in science related to the word open and how it's much more complicated than it sounds and the implications of it are "
    },
    {
        "start": 4995.84,
        "text": "profound and those of you who are going to be leading us forward you're the ones that are going to have to wrestle with all this stuff and I'm going to pick three uh papers that bring these complications out in different ways and tell you from the point of view of the stage manager uh how how this open thing is going to play out and of course there's a lot of good that's going to come out of it it already has but there are a lot of complicated things to think about um so first just the slides that I show at the beginning of every talk uh and you know I usually talk to General audiences so you probably know where to find us on the internet and you probably know about our six journals uh the impact factor of science is 63 which is either really impressive or something that you should ignore depending on how you uh view impact factors and H indices and all these crazy things that we have "
    },
    {
        "start": 5058.26,
        "text": "but I can tell you we had the biggest jump ever this year and the reason was because of coven so one thing you can watch uh after next year I think you know we'll probably sustain it but after next year a whole bunch of these prestigious Journal are going to have their impact factors go down when these coveted papers are no longer in our impact factors and that has never happened before so this will be a very entertaining sociological experiment for you all to observe because everyone has been bragging about the their impact factor is suddenly not going to say anything about it because it's going to go down um but of course it's nothing but just an artifact of of what we went through with the pandemic um the science journals the five subscription journals are different from the journals that I grew up with uh in the American Chemical Society in that uh the people who make all the decisions and handle all the papers for us it's "
    },
    {
        "start": 5119.679,
        "text": "their full-time job uh to do that and for those of you you know we're talking about jobs today it is a really wonderful line of work um and uh there's a lot of vacancies uh just like there are across the the labor market and so it's something for you to think about you get to work from home you get to go to conferences you see all the great science in the world um and uh you know we had a lot of people who get in that job and stay in it for 30 years because they really have a good time doing it they're brilliant brilliant people um somebody who reads papers for a living is just as interesting to talk to as your faculty or graduate student colleagues at a great Department like this they're just unbelievably powerful Scholars uh then we have a one large Open Access Journal science advances and we use academic editors uh there like like all the ACs journals do and and many of the journals that you're publishing in uh the the the the parent Journal science is three different things "
    },
    {
        "start": 5179.8,
        "text": "it's a research journal in the back uh that um I think I had this on the previous slide uh gets 12 000 submissions we publish 750 of those the other 11 250 people are mad at me um uh but uh yeah if I ever write a memoir about my time uh in this job it'll be entitled sorry we didn't have better news for you uh which is something that I say to a lot of people every day um but um we're we're proud of what we publish uh and we think it has a lot of impact uh the other thing in science is the news Department we have 30 journalists that work for us uh they they all went to journalism School their their very traditional journalists like you see in TV shows about journalists they go through people's trash and uh steak out there their Labs um and uh and file public records "
    },
    {
        "start": 5241.0,
        "text": "requests and write edgy stories about things that are going on in science um you know there's an opening for the director of the Salk Institute which I think we're probably responsible for um and uh you know we've we've exposed a lot of other uh great things and there's a lot of careers content that we and all of our competitors uh are using the hope you all find interesting and our journalists all over the world it's a huge amount of fun to work with these folks they're editorially independent of me which means I can't tell them what to cover I can't tell them not to cover something but if they screw up it's my problem um and uh and that's okay because I really enjoy uh working with them um and then we have our commentary section insights you see the five different types of uh content we have there uh this is where scientists talk to each other so unlike um unlike a lot of "
    },
    {
        "start": 5301.06,
        "text": "opinion uh Outlets our opinion Outlet is an outlet for uh for scientists to write opinions for other scientists and we think about science as a journal you know a lot of people say well do you want to can you make something for K through 12 or can you make something so that I can convince my climate denying uncle that climate change is real we don't do that stuff Scientific American and the Discovery Channel and Weekly Reader they they all do Sesame Street they do a great job of that stuff um we our magazine is for scientists so it's for scientists to talk to other scientists it's news that scientists want to read and it's research that scientists want to read um how do we do impact the public in in a few very important ways the most important is uh when there's news coverage of our research papers and we have a whole team dedicated to making sure that uh the papers get covered and that they're covered accurately "
    },
    {
        "start": 5362.679,
        "text": "and this is a major issue in science because when the mainstream media and we saw this big time in the pandemic when the mainstream media covers a paper and does it inaccurately that's what the public reads so if that's inaccurate then that gives the public a way to say that we don't know what we're doing even though our paper is accurate the news story is inaccurate that's what the public sees and this is a major major Challenge and it's really only science and nature that have teams that that work at making sure these things are accurate and go back and get things corrected if they're wrong that's a very labor-intensive thing and so when people pay for science the team that that handles the earned media coverage is one of the big things that they're paying for um and uh I know your librarian's not here but that's a plug for them uh to keep uh their subscription up with us "
    },
    {
        "start": 5426.04,
        "text": "okay so look who doesn't like the word open right I mean it sounds good you know let's let's have let's have this open that open uh everything open nobody wants anything closed people don't like Baywatch people think that all information should be free and democratized and of course that that sounds good and there's a lot of great things about it but we've got uh so you know here's the Merriam-Webster's open having no enclosing or combining barrier accessible On All or nearly all sides all right that sounds that sounds good okay uh but it's complicated to do um and I'm going to show you some examples where that's true okay the first is in what we refer to as Open Access which is the idea that the final the version of record of a paper should be accessible to everyone uh even if they don't have a subscription to the journal uh "
    },
    {
        "start": 5486.94,
        "text": "the challenge with this is that all these things we do the journalists the people who do earn media the people who work for us full-time managing a Twitter feed with three million people on it you expect all these things to be done by us we have to pay them for them somehow and what happened in the early years of this Open Access idea is that the commercial Publishers figured out hey this is great we'll just charge the authors to pay us to publish their paper and there's a whole bunch of and you don't see elsevier and Springer nature and and Wiley who are the main commercial publishers yelling and screaming about this Open Access thing because they love it because they don't like negotiating with the Librarians for their subscriptions they can't get very big price increases that way but they know the authors really wanted to publish their papers so if they can charge you eleven thousand dollars to publish your paper in nature and make "
    },
    {
        "start": 5548.56,
        "text": "it open access and they can get the federal government to tell them you have to pay in that then not only is I mean first of all they're still getting their subscription fees at least for the time being so they're getting that from the Librarians now they're getting 11 000 from you and you're at the big old bad Mojo Factory the University of Michigan which has enough money to pay the eleven thousand dollars but what if you were in uh what if you were in ecology and all you had was one NSF Grant what if you were at an HBCU or in a low and middle income country and you couldn't pay eleven thousand dollars well then you can't publish in nature um and that's that's not good for anyone so this Open Access sounds good because it means everybody can read it but it also means that if if we're going to subsidize all of these functions "
    },
    {
        "start": 5610.9,
        "text": "that's going to end up getting charged to Grants and that means only people with a lot of Grants are going to be able to publish and if you need papers to get grants and you don't have any papers yet how are you going to get a grant if you can't afford to publish all right and so there's a lot of inequity baked into this the other thing is that um then the the the underlying papers are all being given to these commercial entities so as Gil pointed out the science journals are non-profit we do make a surplus and we give that Surplus to the American Association of the advancement of science to do all the important things that they do in science literacy science diplomacy all of all of these uh science policy all these important functions the the commercial Publishers make a surplus that they return to their shareholders uh and now if they so you probably never even noticed this but if you publish an Open Access paper either with an Open Access journal or by "
    },
    {
        "start": 5671.56,
        "text": "paying an additional fee to a subscription Journal you get what's called a ccby license okay now that's ccby license not only means that it's the paper is available to lots of people and free it means anyone can take that paper and change it and do something else with it so somebody can take your paper scratch out the part that they disagree with and publish it again with their own stuff on it and they don't have to give you anything for it that's what that ccby license does and most people don't even know this is happening all right and so you are you know I guess so A lot of people say well I don't like signing that copyright form that gives the copyright of my paper to to science or the publisher but but when you get that ccby license you're giving it to every publisher and they can do anything they want to with it uh so this Open Access thing is pretty complicated it's creating a "
    },
    {
        "start": 5733.239,
        "text": "barrier to publishing in exchange for lowering the barrier to read and that sounds good A lot of people weren't paying attention to this this whole thing got this way and now we're getting ready to pay a big price for that okay open data right so you all are putting your data on zenodo or and your code on GitHub all right and most of the time you can do that for free but eventually as we put more and more data up with every single Paper the cost of storing that and the cost of maintaining that is going to go up and up and up and eventually and it's already happening there are a lot of commercial entities that are going to want you to pay them to host that and not only are you paying them to host it but you're giving it to them so that they can use those data they can resell those data and they can use them to come to their own scientific conclusions and uh you know you're creating these behemoths and eventually you know if "
    },
    {
        "start": 5795.34,
        "text": "elsevier does that then they'll get good at it and Amazon will buy it and they'll merge it with one medical and you can imagine you know what's going to happen to all those data that you with federal dollars generated you're you're if you have to deposit them you're basically giving them to Amazon and elsevier and whoever else for free all right open code same same issues there who pays GitHub uh and um you know how do we decide that it's the actual code okay the author says it's the code but do we know that same thing with open data we don't go trolling around the internet to make sure that authors didn't put up their code long enough to get the paper I mean the or their data long enough to get the paper published and then take it down we can't afford to do that who's going to do that so these are all complicated questions related to all this and I'll take you through three little sagas about that first on Open "
    },
    {
        "start": 5858.639,
        "text": "Access I I said all this stuff but here's here's our policy um which is in this editorial you notice I'm not an author on this the way science works we have a publisher that's the person who does the business side I'm responsible for the content and then suda Parikh who's the CEO of the aaas is the executive publisher so something like our open access policy that's their that's their deal I'm supposed to make the best content in the world um and uh they're they're the ones and Shirley Malcolm somebody who works with us on lots of equity and social justice issues and she's a an American treasurer for those of us who know her but in this uh article they lay out what our policy is which is we're allowing we're not taking money to make up papers Open Access we're allowing authors to take the accepted version of the manuscript not the final one where we've fixed all the illustrations and put all of our all the links in and all that "
    },
    {
        "start": 5920.86,
        "text": "stuff and copy edit it the version before that and deposit it anywhere they want and eventually it'll be on PMC um and you can say wow you're giving away a lot there well we are um but the alternative is to charge for it and to charge direct costs into into grants and we don't um we don't think that's good for science so we're hoping that the Librarians um will continue to buy our subscriptions uh and um and that uh we can we can do this as a way of satisfying the demand that people have for open access without double dipping like the commercial uh Publishers are doing and one thing about the paywalls whenever you see somebody on social media complaining about a pay wall on a paper it's almost always somebody who works at a university that has a license they're basically just saying they can't be inconvenienced to log on to their VPN to read the paper and I'm sorry you know "
    },
    {
        "start": 5982.12,
        "text": "if I'm if I'm if I'm an author in a low-income country and I'm going to be excluded from publishing because someone at the University of Michigan does thinks it's too inconvenient to go on their VPN you know that that doesn't that doesn't hold together as far as I'm concerned so you know uh I know it's a drag to log onto the VPN if you're at home but tell your librarian to make the VPN better you know um okay so you know I usually give these talks for very general audiences I'm bringing the calls to Newcastle with this uh with this slide but I know I think I think you're probably all familiar with the work and use applying artificial intelligence to protein structure prediction I know there are groups here that have done a great job with this I'm going to talk mainly here about the Google group and David Baker's group but you know this is how I explain protein folding to a much more General audience than this but there's an "
    },
    {
        "start": 6042.6,
        "text": "important thing here because uh uh the solution to this required two things that relate to open access open code and open data one is that the pdb had to have been built because we wouldn't have Pro we wouldn't have had this protein structure prediction without somebody having the vision to build the PDP whenever it was 30 40 years ago and the other is what's that even longer yeah um and uh and you know it's no good if the code isn't available to everyone because then you know it's just Google we're winning a contest it's not actually taking protein structure to everybody who deserves a chance to use it uh so you know again this is how I explain things but this is a also a plug this is the drug I developed this is the crystal structure of it so I always like like to show this um but of course this is the reason why "
    },
    {
        "start": 6102.659,
        "text": "we this is one of the reasons why we need um uh we need accurate structures so that we can do this without having to get a crystal um and you know I like to tell audiences that this all started with with myoglobin uh Brian was correctly saying lysozyme was also important but uh lysozyme doesn't have a metal in it so I like to show this one since I'm a bio inorganic chemist but this is where uh things started and uh here's all of here's the first uh 50 years of this uh we went from perutes and kendru winning the Nobel Prize for for myoglobin at six angstroms in 1962 and then another Nobel Prize for cry OEM in 2017 where we got to the point where we didn't have to crystallize the the protein in order to get these structures um but then we get to the state of the art in in 2012 I didn't plan this but I guess 2012 cast started the same year "
    },
    {
        "start": 6164.76,
        "text": "you started your department is that correct yeah okay that's when you started winning even better yeah um cath started in 94. wow okay um so this is some paper I found with a bunch of the uh cast structures from 2012. um you know these are these are relatively small proteins but everybody was still really excited about this I was in an administrative fog at the time this happened so I didn't know I didn't learn about this until more recently um and like I said this is from my predecessor Jeremy Berg who points out uh eloquently at the time that all of this kind of came to this conclusion that you know we wouldn't be where we are if it hadn't been for The Visionaries who set up the um pdb and you know he goes through this is the most important paragraph of all this uh "
    },
    {
        "start": 6224.76,
        "text": "you know that um the cultural shifts were often whoops controversial but it's hard to argue that uh you know the structures wouldn't have happened if it weren't for uh the pdb and the structural prediction uh problem has been solved it's hiding in the pdb he says you know and I think that's um absolutely right and so on the good side of open is the pdb and The Visionaries that set it up and figured out how to host all the data and made it so that we can download the viewer and look at all the structures and you know people who came along later just take it all that for granted that it's straightforward to do uh I'm kind of in the middle on that you know we certainly in the 80s we had plenty of protein structures but you couldn't just get on a PC and and play with them um till much much later than that so all of this has has come along during my time in science "
    },
    {
        "start": 6288.199,
        "text": "there you go right foreign yeah so once the pdb came to the internet it was pretty amazing all right so you all know this um deepmind started winning Casp um and of course they got a huge group at Google that they applied to this um of course I haven't this animated in the PowerPoint version of this talk but I knew you were P PC people so I sent PDF for my slides so but you've all seen these movies million times before anyway um Google wins Google's winning cast they are obviously closing in on the answer to this um but initially their algorithm was uh not widely available so they they get you know right after the latest cast that they won uh of course we know there's going to be a big paper on this they've always been nature people on their protein stuff but of course we had "
    },
    {
        "start": 6349.38,
        "text": "to make a run at trying to get the paper so we talked to Dennis and told him how great it was that he'd accomplished all this stuff how it would look great on the cover of Science and um everything else we could think of to tell him um but he uh and we made a decent pitch but he decided to go to Nature but in those conversations you know it came up well what are you going to do with the code if we publish this will everybody be able to to uh you know go somewhere and do their own predictions or how's this going to work because up until that time you know that code was not widely available um and you know we probably would have taken the paper if if some kind of agreement that we probably wouldn't have been thrilled about about the access uh because it was a big enough paper and we wanted it but um "
    },
    {
        "start": 6409.8,
        "text": "you know we were worried about that and we were debating that so he goes to Nature we're we're licking our wounds and saying oh well you know we tried to get it then we get a phone call from David Baker who says that this brilliant postdoc of his Dr bike has figured out how to do this a lot more uh inexpensively and uh that they want to publish the paper with us and they're going to make the code freely available so we thought that was pretty awesome we wanted to get the paper out before nature did uh we reviewed it pretty got it reviewed very quickly uh the reviewers got all over their algorithm and tested it um and I don't know somehow nature found out we were up to this uh and so these two papers ended up getting published on the same day and lo and behold Google decided to make their code much more freely available than we were expecting so this is a great story uh we're proud "
    },
    {
        "start": 6469.8,
        "text": "of the part that we played in um in catalyzing uh this and you know now now you all can decide whether Alpha fold or Rosetta fold is better and you can pit them against each other and um and that's the way it should be so this is this is open code doing doing for good all right um and this all played out really great and we made a breakthrough of the year um and I wrote a glowing um editorial which I always write for the Breakthrough of the Year saying the protein folding problem was solved and a whole bunch of biophysical chemists got very mad at me because of course they don't see AI structure prediction as solving the protein folding problem they just see it as a way to get the structure so I'll again I'll let you debate that with them as well um but I love it if you argue with them and end up generating some great papers that I can publish uh and "
    },
    {
        "start": 6530.639,
        "text": "um you know very similar to that um we started getting papers on RNA structure prediction there's a lot of commercial activity uh in this space um I have to have a disclaimer because I'm actually a partner of venture capital firm that owns part of ribometrics but rival metrics has got a lot of great competitors and um RNA targeting by small molecules is super hot in the biotech space right now and using these same principles to get RNA structure may get us more drugs than than on the protein side who knows but that's exciting too all right so that's that's the protein folding story now let's go to another even hotter topic uh which is where covid comes from um and I'll just kind of take you through the timeline of how things have evolved so uh and we've been we've played a very important role in this throughout uh the time "
    },
    {
        "start": 6590.94,
        "text": "that this has been going I'm waiting I'm making sure I've got plenty of time before Brian yells at me um so uh so in the early days of of covid um you know there wasn't a whole lot of discussion about where covet came from there were some people saying oh the Chinese must have engineered this or was engineered in Chapel Hill uh or uh but there was most a lot of people thought it came from the wet Market uh in Hunan in Wuhan um and not a lot of discussion well then you know there's pressure from politicians and eventually the who sends a team to Wuhan to look at this and they wrote a report that said that it almost certainly came from an animal we call that zoonosis um and that it was highly unlikely that it originated in a laboratory which turned out to be correct but a lot of people felt and I agreed that if we were going to defend that conclusion to "
    },
    {
        "start": 6652.8,
        "text": "all the conspiracy theorists and politicians who were trying to tell us that was wrong that we needed to do a better job of ruling out the lab leak uh hypothesis more rigorously so we published a letter which a lot of people objected to but like I said you know when we get in trouble that's my decision so it was ultimately my decision to publish the letter from Jesse Bloom who's in the upper right hand corner of that picture who's a virologist uh Stanford probably the most prominent virologist who still thinks that the lab leak theory is viable and 14 or 15 other uh scientists who all felt that um there should be a more rigorous investigation of the lab leak now a lot of those people who signed it were not necessarily and me in terms of deciding to publish it we're not necessarily people who thought that the lab leak was more likely or even "
    },
    {
        "start": 6712.86,
        "text": "somewhat likely but who felt that the lab League should be more rigorously ruled out if we could so that we didn't have this lingering debate about all this um and uh but a lot of people criticized us as saying that by publishing that letter we were fueling the conspiracy theorists um so looking back on it we're pretty happy we published the letter because a lot of the authors who are on there did start digging into this and came much much further to the conclusion uh that zoonosis is is so much more likely as the the lab leak is is almost explode completely ruled out and one of those is Mike Warby who's on the in the middle on the top of that who's um professor at Arizona and I'm going to describe his paper to you so Mike uh signed the letter saying we needed more investigation and then went and did the investigation uh in the lower right is Alina Chan who's one of the strongest "
    },
    {
        "start": 6774.659,
        "text": "proponents of of the lab leak um in my opinion mostly on behavioral evidence not scientific evidence and then that's Lin faw Wang who's uh hardcore zoonosis guy and in the upper left is John Cohen who is our journalist who covers all of this and uh if you haven't seen it I highly recommend uh the HBO documentary how to survive a pandemic which is all about John Cohen going and finding out a lot of this stuff um and he's a great and entertaining journalist in every respect and he hosted this debate that we had about this uh then we started publishing um uh uh papers about this um you know some mostly perspectives at the beginning before there were data eventually we published this um perspective from Mike Warby himself this is a map of the early cases of covid um and you can see uh here's the here are the two Labs "
    },
    {
        "start": 6836.4,
        "text": "here's the market and the cases are mostly around the the market um you can just tell that with your eyes uh there are a few cases down by the lab but not nearly as many as there are up here so uh this was kind of the first stake in the ground here um but eventually Mike's group did a much more rigorous um study of all this uh which we published about uh I don't know eight weeks ago and um these papers so here's the first Open Access part of this these papers were all in pre-prints all right everybody here knows what preprints are I'm sure science is very much in favor of pre-prints because we we like it when uh the experts can go ahead and start talking about their data and we don't think it takes anything away from us when we publish the paper because if something's a pre-print even if it gets covered in the news when we publish it it's way bigger because we "
    },
    {
        "start": 6897.719,
        "text": "have all these teams that make sure that our papers are heavily covered and that was certainly the case with these um so these were in pre-prints they were controversial and our you know the lab leak crowd was all over social media taking them apart but we had them reviewed we studied them very very carefully because we knew they're going to be read on the floor of Congress and whenever that happens um you know we it's all hands on deck so this figure from the paper these are the cases that the World Health Organization has in their data uh from the from December of 2019. and um the uh the orange cases are ones where there was a known link to the market and the blue cases are ones where there was not a known link to the market and uh as you can see just with your eye they're pretty well aggregated around the market even the ones that don't have a known link and of course the other open part "
    },
    {
        "start": 6959.04,
        "text": "of this is that these data were on the internet and and Warby was able to get them to analyze them uh and here's uh you know these are pretty simple calculations to do but if you calculate the epicenter of all these cases centered in the market if you take the linked cases out you still get um uh a pattern that's aggregated around the market um and if you then take even more data uh everything not just the who data but data from lots of sources those also uh Center on the market and these are the centers of all of those and over here that's the center of the Wuhan population so if it was totally random you'd expect it to be over here and all these different subsets um are all of these points over here and uh what's really important about this "
    },
    {
        "start": 7019.82,
        "text": "which I'll say more about in a second is that there's another paper that uh that the same group published showing that there are two distinct genetic lineages of these early cases um and both of those lineages are also centered on the market okay here's a this is a great kind of open data thing these are uh check-ins of different sites on social media in Wuhan right so these are Supermarket shopping malls um this is how many people you know it's a big city these are how many people checked into the most uh the biggest one you see buildings hospitals schools markets all the way down here is the who is the Hunan Market so it's the Hunan Market is not the sender because there are a lot of people going there compared to other sites where the virus could have spread uh more easily "
    },
    {
        "start": 7080.84,
        "text": "and then here's a figure that shows a a map of the market itself uh this is where the animals are kept and all these little squares are with where there are human cases so almost all of them on the same side of the market where the animals are there are a few over here on the other side um so all of this pointing pretty strongly to the market being um the the epicenter and that the animals are the source of um the the virus and it's hard for us to understand but there are millions and millions of of live animals being traded in these environments and so the flow of animals uh through the wildlife trade in China is just um absolutely enormous and uh you know that's a very conspicuous uh fact in this and the other thing that's important is that this is how we got "
    },
    {
        "start": 7141.38,
        "text": "SARS one so even if you were to Discount all this you'd have to say that there's some reason why we got SARS one from zoonosis where we actually found the animal that started it and somehow SARS too didn't form that way okay so uh like I said the same group had a paper that we published together uh on the molecular epidemiology of this there are two distinct uh lineages um and the first was introduced around November 18 2019 and the second was probably a couple weeks later right so now go back to the the map and ask yourself how you could get this map given these facts well you'd have to have somebody at the lab who got infected by an animal or or you know ridiculously by an engineered virus um "
    },
    {
        "start": 7201.44,
        "text": "that they made or I don't know I don't get how that part works but let's say that let's say they had they had an animal that they took to the lab that had covet they got infected they'd have to go to the market in fact an animal or a human and go back to the lab and not infect anybody else and two weeks later somebody with a different strain would have to go to the market in fact another animal and go back and not infect anyone okay so does that rigorously rule out is it completely ruled out the lab League well no because we're all scientists and we know we don't ever completely no rate constants are zero and and every every uh every finding is subject to more investigation um do I think it's likely that we'll get a paper about the lab leak that we'll want to review that that will uh that will blow this up I think it's extremely unlikely would we review it if it was credible you better believe it you think this is "
    },
    {
        "start": 7262.4,
        "text": "big just imagine if we got the paper uh that um that proved that the lab leak was right but of course you know I think we'd have to it'd have to be very rigorously reviewed and I think it's very unlikely that that's going to happen so you know a lot of the people who shoot at this say well this is all group think because the scientists want to make themselves look good and don't want to make it look like they're sloppy in the lab or whatever um I would definitely review the paper if I got a credible paper about the lab leak I promise you so um that you know that's what's great about science the fact that we love proving each other wrong is a major protection device that we have that the public doesn't appreciate all right so now the thing about these papers being in pre-prints is of course all the lab leak folks read the preprints very very carefully and when we published them "
    },
    {
        "start": 7323.119,
        "text": "they were toned down compared to what the authors send us sent us this is what happens with every paper we tone down every paper we don't allow the word first we don't allow the word breakthrough we don't allow the word uh novel we don't allow the word you know we don't let people hype papers because if they're in science they're already height they don't need to be hyped anymore am I going on Star Tours yeah okay all right um so sorry I live in Orlando I hear I hear that that's the star Star Tours uh sound um so we don't need to Hype uh papers um so we tone them all down and you know the the conspiracy theorists gotta you know they had the word dispositive in there okay we we said okay guys dispositive is a little over the top um because of course you know we wouldn't want to tell anybody because "
    },
    {
        "start": 7383.54,
        "text": "you know the first thing is going to happen eventually they'll be hearing in Congress Mike Warby will have to go there Rand Paul will say is there a chance that there's have you completely ruled out the lab leak and he'll have to say well no because you could have this sequence of very improbable events that we can't completely rule out so we and then Rand Paul would say oh well you said it was dispositive we didn't want that to happen so we we changed things like we changed it to stuff like strongly suggests okay and highly supportive um of zoonosis and stuff like that and the conspiracy theorists think that the reviewers made us do that because they weren't persuaded by the data they weren't I and Caroline Ash and valda Vincent who worked with me on these papers we're the ones that that made those changes and we you know we know these papers were going to be highly scrutinized we went through every single "
    },
    {
        "start": 7443.659,
        "text": "word of them um and uh it wasn't because the reviewers weren't weren't uh weren't convinced so that's another Open Access part because the pre-prints allowed the comparison with the published version and the open data part is that all these data were were accessible uh and the pup political part uh is that a lot of people said uh that well um and this gets to a lot of stuff Brian was talking about uh about anti-asian bias in America that um you know the the people who are the liberals who are pushing the zoonosis uh are um doing what the Chinese government wants well we at least as far as science is concerned we love Chinese scientists we don't necessarily love the Chinese government anymore than we love the American government "
    },
    {
        "start": 7504.739,
        "text": "um so uh and the the Chinese government is pushing the theory that is just as improbable if not more that somehow the virus was transported into China and then um and and it didn't come from an animal that that was raised in China um so and we have a big news story about that that John Cohen wrote called Anywhere But Here that's the that's the Chinese government's slogan about this uh which I think is is just is wrong so the conspiracy theorists who say that we're pushing the zoonosis uh because you know we want more Chinese papers in our journal or because we're um you know we're to whatever they think we are Cooperative um uh you know the Chinese government George gal who's the head of the Chinese CDC is cranky with us uh that we publish "
    },
    {
        "start": 7568.46,
        "text": "these papers just as as much as Rand Paul is so um you know the science has to ultimately be the thing not the not the not the political part but it's certainly not true that um that this is some kind of scheme to to to reward the Chinese government by by sorting this out and I wrote a very tough piece at the beginning of all this about the failure of China to disclose uh more information about the pandemic early on okay one last thing uh example looks like I'm going to be perfect because this one's short um about open data so uh these big companies have a lot of amazing data I mean you could tell that from Aaron's talk just now and I'm sure Dan has got some nice stuff on his servers um that the world would like to see um and that could drive a lot of great science "
    },
    {
        "start": 7628.58,
        "text": "yes but you know the Nordstrom and and strata want to charge people uh to look at those data um and there's a lot of this coming now in social science because Facebook and Linkedin are sitting on the greatest treasures in the history of of social science data and the science scientific world could do two things about this we could say we're not going to publish all that because it came from proprietary sources or we could try to partner with them to come up with ways to use their data to do important things in science um and so we've we've started venturing into this so this is our first foray which was just from last week there's a there's a um a big theory in in social science called the strength of weak ties and for all the grad students who are going to be looking for jobs what this says is uh you know if you met me today and you "
    },
    {
        "start": 7690.26,
        "text": "friended me on LinkedIn and then you asked me to court to connect you to somebody to help you get a job that's more likely to work than it is for somebody you've known your whole life that weak ties are actually more useful than strong ties and there are lots of ways this plays out in social science this theory has been around for a long time tested many times but there's no better way to test it than with the data that LinkedIn has because everybody's on LinkedIn because they want to get a job so it's very easy to measure the success and Linkedin has incredible uh data on on the strength of you know the connections that people have to each other uh so LinkedIn made a bunch of these data available to some outstanding social scientists uh they sent us a paper we reviewed it we worried a lot about the terms so you "
    },
    {
        "start": 7751.04,
        "text": "can see what we agreed to here all original analysis code aggregated data and annotated code sufficient to replicate all correlation regressions are available here we know this whoops we know this link works um individual level data supporting the study are not public available to user privacy and other legal restrictions researchers seeking replication should submit a request to LinkedIn uh and you know they get to decide whether they give you the data or not all right is that perfect no what I've preferred it if LinkedIn just said here's all the data that we pulled this from sure they weren't going to do that so we had to make a decision whether to agree to this uh or not and whether to publish his paper we got a bunch more of these in the pipeline and they're all Blockbuster papers this paper was all over the news and um this we think this is maybe not even the most significant one that we've seen "
    },
    {
        "start": 7812.119,
        "text": "um but still proud to publish it and it was great excellent science paper and big deal in social science uh you know we're getting some serious snark about this um some of it we deserve you know the New York Times wrote a tough piece if you're in the if you're in the data science world as you all are I actually encourage you to go read this even though they said some things about me not me personally but about our Journal that I didn't love um but you know they framed the the problem here so guess what this study came out great for LinkedIn okay because it shows that if you're on that LinkedIn is a great way to find a job because that's how you can get the most weak ties all right so how do we know that so if if the data hadn't shown that would LinkedIn have given it to us probably not yeah um uh not probably not they wouldn't have um and of course then there's another thing which is this experiment was done on millions of people who didn't know "
    },
    {
        "start": 7873.619,
        "text": "that this experiment was being done now you know when you create your LinkedIn account you click on something that says I agree that you didn't read that gives them the the ability to do this so you know that's I bring an awareness to that is good I guess and so you can see some uh researchers who are kind of activists in this space and this is a guy we love Detroit who who works in this space but he was not happy with us um for for doing all this stuff and you know I see where he's coming from but I didn't have the option so you know he's saying we should have just not published this well it's a very important theory in social science we vetted all the terms with really experienced social science researchers they agreed we should go ahead with it we peer-reviewed the peer review in a sense uh when we did that and uh you know it's a high impact paper so we decided to publish it now "
    },
    {
        "start": 7936.32,
        "text": "I'm glad we saw this because we've got a bunch more in these in the pipeline um and you know watching how this played out helped us think about how we could do this better in the future and what we might get out of it um or how we might you know lower some of these concerns but these are the questions we're all going to be wrestling with because if linkedin's not showing their their data let's say Dan decides he's going to let you write a paper about his stuff and it's awesome and uh proves a big thing about uh cancer and we want to publish it um how are we going to go about deciding whether that's you know we've adequately controlled for all this stuff uh that's a work in progress and so I think the point of this whole talk when it comes to open access open code and open data "
    },
    {
        "start": 7998.0,
        "text": "is as I said the devil's in the details it sounds good to have all this stuff open but you all as you go forward in your careers are going to be spending and even right now are going to be spending a lot of time peeling this onion because every time you think you've figured out every way to make the code available there's another thing that comes along or you know I have a really cool job in so many ways and you know sometimes I have to decide things like well we got this rock out of the bottom of the middle of the ocean and here's what we concluded from it about the evolution of the Earth but we can't make this rock available to everybody so what do we do about that or you know we got these fossils and we can't make them available because they came from this uh indigenous land and we can't take it from there so we "
    },
    {
        "start": 8059.619,
        "text": "can't put it in a repository where other scientists can come observe it because we'd be uh you know appropriating it um and we're got and now we got all the same things with data and the code and the papers who can change it whose verifies it's right who pays the story uh and who decides that enough is enough in terms of what's open and what isn't so that's those are the challenges I leave you all with I'm happy to hear your thoughts about this this is uh something that's going to continue to evolve um and I'll skip that since Brian's about to yell at me and um here's the team uh that brings you Science magazine every week like I said these are the some of the smartest people I've ever worked with and I've been in a lot of great academic departments in a lot of Great Schools but these are brilliant Scholars who read papers for a living and um they have an unbelievable ability to "
    },
    {
        "start": 8121.42,
        "text": "determine when they're correct and when we should publish them and um you know I think of them as my faculty colleagues in every respect so thank you so much Gil it's an honor to be the omen lecturer and congratulations to your department on 10 years of great success [Applause] exactly we wanted to have a family discussion because we really wanted to see explore some things okay to get started so I I I because it actually has to do with Aaron and your talks because if I have to if I have to uh moderate this I need people to moderate "
    },
    {
        "start": 8186.179,
        "text": "thank you [Music] all right so uh so while everybody's getting ready and they're they're doing something around here um I I actually want to say congratulations to Brian and Gill on the 10th anniversary I'm actually probably the only person probably the only person that does not have an appointment in the department but I actually have published I I think I counted eight people that I published with uh I'm here and and I want to thank Brian and Gil for all the support they've given me in developing the programs that we've been doing so I actually I'm glad I got to a chance to say this in public all right so um um I'm going to start off with one question and then I want to open it up a little bit to um to do it so you know a lot of things in in June it's I'm glad you're here too because June is one of the people at home um the um uh it's it's leadership "
    },
    {
        "start": 8246.639,
        "text": "um you know uh you know all of you are leaders in in your own way and um but I'm wondering how you learn to be a leader um because this is a really important thing to really get things done uh especially if you're gonna uh continue to lead or want to lead groups and and not working by yourself and so I wonder if you could uh address um uh what the ups and downs you know uh and and and is this natural do you learn it um and how and and how does this uh evolve so I think the uh Holden you obviously have risen to or leadership positions and I'm going to get your uh impression first but then I actually want to bounce it out to to uh actually talk to Aaron too because yeah well I've talked enough so I'll just say something that I already said to the students which is the most important thing about leadership is that positive reinforcement works and negative "
    },
    {
        "start": 8307.54,
        "text": "reinforcement really doesn't and um so and I learned that from Harry gray my research advisor who's the world's most positive person uh he's a wild extrovert and all he does is just tell you what a great job you're doing and then occasionally he tells people to leave graduate school um but he doesn't do anything in between because when you give people tough feedback no matter what HR tells you it actually doesn't work it makes him perform worse and uh I knew that when I was running my lab I struggled to learn that again when I got into you know the spotlight more in leadership but then I later figured out you know what that was right all along um and so especially in this labor market where people are getting out of the workforce uh being a source of positive encouragement is the num Leader's number one job thank you so yeah I agree it's very important and uh I really also want to "
    },
    {
        "start": 8368.38,
        "text": "Echo something that Dan said to me it all starts with feeling passionate about what you do because without that I don't know how you can sort of lead anyone and uh so I think uh also it is about creating an environment in which people feel comfortable sort of expressing their opinions in uh I think that sort of you know ultimately leads to Great results so that's just thanks so I'm going to pin you down Aaron because you you now you now are a leader and um and and and so you you had a I don't want to say subservient uh position at uh at the clothing manufacturer uh but um so you know how how did you grow into this because because I I know you very well but it's uh and I think I know but sure uh so just like uh we were saying "
    },
    {
        "start": 8429.76,
        "text": "we talked about this a little bit at the at the student lunch and for me that was a really natural progression going from being a technical contributor to then ultimately kind of setting the strategy and agenda and then recruiting and building a team but I think in terms of just what's the important shift that has to happen for you to do that I think one is the recognition that you got to that space because you were excellent technically in my case for example but there's a shift that has to happen for you to continue sort of being excellent as a leader and I think one of the core pieces of that is really the change of mindset and the recognition that it's not about you anymore and that your success is your team's success so instead of thinking about my technical contributions or you know making sure that my name is on the paper it's more about what is what's in my team's way what is the barrier for their success and then my job or where do they want to go in their career and then my role "
    },
    {
        "start": 8491.319,
        "text": "becomes uh enabling that to happen or making sure that they have the right types of work to uh to grow the skill that they that they're trying to grow and to get to unlock the next stage of their career so it's it's really just a mindset shift that the way that you succeed when you're when you're moving up to a leadership uh role is is not your your Stellar work in the spotlight on you it's your team's success and then of course you get to share in that as well but uh yeah it's just a difference in focus okay thank you sure yep [Music] analysis of this page charge thing you know one of the things that you said that um bristled me a little bit was that to Mighty Rich University of Michigan could easily afford these eleven thousand "
    },
    {
        "start": 8553.24,
        "text": "dollar page charges and the poor guys out in the Hinterlands couldn't uh well the assistant professors here I couldn't do it either and you know it's it's going to create some kind of uneven playing field so you have the the forces of thou savior or Springer verilog over here you know you have the forces of uh bio archive and much archive over here you have a unique situation with the science journals uh you know you have the libraries and transitions still towards a fully digital remote maybe even non-existent State I mean what's really happening here and what needs to happen and how can we how can all of our experiences and I want to hear from that you know kind of inform this because we're running into a little bit of a train wreck I think yeah we certainly think so and um yeah of course the assistant professors first starting out who's been in their startup packages um can't afford eleven thousand dollars "
    },
    {
        "start": 8614.56,
        "text": "either but it's also true that the university the Provost of the University of Michigan could fix that problem um but the Provost of Morgan State can um or you know I was thinking you know Western Michigan um and so um so yes I think it's a train wreck and uh if just think about it if every single Paper becomes an APC paper and the the average is let's say three or five even five thousand dollars per paper but every lab's got to have at least fifty thousand dollars just for the paid just for the apcs and you know if you're a big old cancer lab okay that's probably doable but if you got one NSF Grant that's a third of it so um yeah the and the the scary thing is if all of it goes that way and I don't "
    },
    {
        "start": 8676.18,
        "text": "think it will but if it did then elsevier can raise the price without having to negotiate with the librarians and that's why they want to do it that's why you don't hear them complaining about it I mean there are a lot of you know these people who are these OA zealots on social media the day that the ostp said this change was coming he said whoa under fell severe is okay and I'm like is elsevier okay they're laughing all the way to the bank um so yeah this is a complicated problem I'd like to hear from my other panelists so it's a big impact and it uh likely will come out of a some kind of non-existent discretionary fund that you know we don't I think you have too much faith in the Provost especially over here at the medical center Indica go ahead yeah I don't have any so I publish in like IEEE Institute of yeah I could put "
    },
    {
        "start": 8736.78,
        "text": "that microphone and and uh so I cleaned as a mathematician so in mathematics like great papers sometimes in open like just put into archive and leave it there and and like two weeks ago one of my paper except to Major Communications so the bill came it was like six thousand dollars I was a little bit shocked but I have in my lab we have funds to pay that but then this week I another paper could accept to IEEE instead of electrical engineers it's free I didn't know I don't want to do anything so and I'm coming from a third world country I'm from Sri Lanka and I really like it to be open like friends in my my country can read papers right it's uh we need to adapt somehow I don't know a solution and and you need to adapt somehow how to make it open source "
    },
    {
        "start": 8797.22,
        "text": "so who I want to ask you something so um you know these these Publishers get a lot of free labor does the scientists have any power in this to change this the the cost structure or or uh you know demand that if you review you know X number of papers you get free paper I mean there's we have the power to withhold our Publications but we need to publish so do they have us um or is there something uh well certainly in certain Fields I mean um you know that's why what we're doing is we're continuing to charge the libraries for our licenses University of Michigan is the biggest so they pay the most we was progressively priced um so your library is paying us about forty thousand dollars to get our five subscription journals sounds like a lot but you're paying elsevier 10 million for all of elsevier's journals so we're banking on "
    },
    {
        "start": 8859.42,
        "text": "the fact that when your librarian has to cut their budget we're not really on their radar uh and so um and so we're just going to start giving away a whole lot more content so that you know if you're in Sri Lanka you can't get past the paywall on our site but you could read the paper on PMC and um you know we're counting on the community sticking with us on this and so you know there's one thing you can do which is if journalists try to do this which we think is a more honorable thing than what the others are doing you know buck up your librarian if they say well wait these papers are on PMC why am I paying for this well you're paying for it so that we don't have to charge you uh more way more than ten thousand dollars per paper so that's one thing you can do and the other thing you can do is try to help more people be aware of the fact that you know these journals have "
    },
    {
        "start": 8920.5,
        "text": "different models I mean a lot of people say to me all the time oh we think of cell science and nature as all the same and in many ways they are uh but if you publish with us you're helping the American Association for the advancement of Science and if you're publishing with cell or or nature you're publishing the shareholders of Springer nature or elsevier so and I think most people aren't even aware of that what do you think do you want me to open up different topics okay I'll uh build on a different topic because hurting you started uh you know earlier talk about how scientific journal editors are scientists who study the behavior of scientists and then you must have observed the different types of authors their style of proving the way they build a case and then you select 750 as published how do you build the expertise "
    },
    {
        "start": 8981.16,
        "text": "among your editorial staff and among reviewers or how to give feedback to those rejected papers so that there is the collective increase of expertise yeah that's a super sharp question and the biggest you know thing that I wish I could figure out is what you raised at the end which is how could we give more feedback to the people who don't quite make it um because that's a lost opportunity um you know so of the seven we we published 750 we review 1500. so the the other 750 that doesn't get published are getting some feedback but the particularly you know the assistant professors or the people from other schools that don't have as many colleagues who've published with folks like us you know it would be great if they were getting more feedback but from a from a cost perspective I mean when you got 12 000 papers to chug through you just got to get to the next one on your queue as as fast as you "
    },
    {
        "start": 9043.439,
        "text": "can and so asking my folks to do that uh isn't in the cards so if anybody has any ideas about how to do that I'm I'm all ears that would be really really important as far as the the editors uh you know we've got a lot of editors that have been around a long time much longer than I have I learned everything I learned now about publishing from them and so we just have a tradition of bringing young people in having them stay in the organization for a good while and them training the Next Generation and um you know again I think the fact that we're non-profit and we're not enormous means that we have more of that than our commercial competitors do thank you so I want to encourage the audience uh do you have questions comments Holden great to have you here thank you for the great talk "
    },
    {
        "start": 9104.28,
        "text": "um as as we're moving into more of a big data world like the LinkedIn paper um that you described how do you ensure that you have the the domain expert review but also the data science review I know in a couple of times years ago I I reviewed papers that I actually wasn't so much the domain expert but I'm a data thinker and dug in and found you know Common flaws and data and that led to paper rejections and have found those sometimes after the fact of papers being published how do you balance those two um and when associations are being identified that that you know that they couldn't have Arisen by chance that that really good rigorous data science and statistics is going into these types of studies yeah so it's not perfect for all the reasons that you just said and one of the things I think is really important is for everybody to recognize that this it it doesn't end when the paper is accepted it doesn't end when the paper is published uh we do about five retractions a year "
    },
    {
        "start": 9166.439,
        "text": "people ask me all the time oh aren't you embarrassed that I have five retractions no I'd be embarrassed if I didn't have five retractions because it would mean that you know a we're not taking enough risks on some of these things to push push the boundaries and B we don't have a robust process for following up on papers when there's a challenge a challenge so I think you know one of the biggest things we need in Academia is to try to lower the stigma of having your paper corrected or even having it retracted because that's just part of the the scientific process and we've got a major sociological problem with that and we're working hard to change that but boy it's tough but you know we had we had a science translational medicine paper a month ago some image sleuths went on and found a bunch of screwed up Western blots if anybody can think of a way to do Western blots without taking a photograph that would be a really good thing for the for science um but you know so photoshopped Western blots uh the lead author didn't know "
    },
    {
        "start": 9228.42,
        "text": "about it we told him about it he as soon as he saw it he said retract the paper if every story played out that way we'd have the scientific record would be way stronger than it is now and so we need to change the behavior of scientists to get them more comfortable with this I I want to go a little bit more into the other data openness and the one-way streetness of it so when the Human Genome Project started it was one of the first projects where all the data were basically released to the public the day it was generated and that was part of the agreement but then a company decided oh we want to do our own Human Genome Project had access to the public data and as far as I know there was a huge debate that people have feelings about of whether they really got the human genome separately or whether they just did get some of the public data and now "
    },
    {
        "start": 9291.12,
        "text": "fast forward we have a database of huge number of genetic data in dbgap that we are obligated as scientists to submit if your NIH funded but the Chinese government has decided that their own data is property of the Chinese government so there is a I've worked in China and I I love the the access but on the other hand the access is a one-way Street they have access to dbgap but we don't have access to their data and I there may be many other examples like that how do we deal with the fact that some people have access to everything when it's open and but but there isn't a reverse Direction right that could have been part of my talk but I'm going to let my colleagues up here respond and then I'll say something if if needed in June or um you already commented on the the political Crosswinds and different "
    },
    {
        "start": 9351.899,
        "text": "nations um in addition to that not not only the the political uh concerns there is also a cultural difference we sometimes wonder why uh climate science and vaccinations such a hard topic here and in China it might be genetically modified food in Europe with animal rights and nuclear energy so it's hard to really study the comments and Guardians Of This concerns in society but that's where scientists are the true citizens who are Without Borders right if we talk in our community we become again World citizens to to help bring some of these barriers is that my comment I have no I I I have no comments about that I teach mathematics of data and then "
    },
    {
        "start": 9412.979,
        "text": "sometimes I wonder the Integrity of data sometimes there are a lot of data how much I trust the data right and I have no comments I was going to take it in a slightly different direction if that's okay so when you you talk when you talk about about the origins of covet I think you um touched on the sort of you know rays of various conspiracy theories and things like that and so what I'm kind of wondering is um what do you think is a way to as as scientists I mean and uh sort of you know being the editor of you know um science uh journals uh so do we have a bigger role to play in combating this because I kind of you know I was you know I grew up in the Soviet Union so I kind of know firsthand we're kind of you know disinformation and propaganda can "
    },
    {
        "start": 9473.04,
        "text": "lead and so I think we should be very concerned about that and how do we come about that yeah so you're you're taking up something that uh is I'm putting a lot of emphasis on and hopefully we'll do more and that is and I'm doing my first outing at GW on this um I mean I I think every body who gets an undergraduate degree in uh in science and certainly anybody who goes on for PhD needs to learn the history of Science and the politics behind how a lot of these things played out because all of these patterns that we've seen and definitely in other countries where you know June's absolutely right you know about the different issues that play out in different places uh politicians uh thrive on doubt doubt is the most useful political thing in the world because and it's way more useful than "
    },
    {
        "start": 9534.84,
        "text": "certainty right so you know my political views are no no secret so you know why did Donald Trump not do anything about you know really investigating Hillary Clinton's emails well because the answer wouldn't be nearly as useful as the fact that he can still use it today because he sowed enough doubt about those emails that is still useful to him right and the same thing is true about the lab leak or about the vaccine causing myocarditis or you know all these things that we've debunked that we've debunked the politicians don't want those things debunked and most scientists are not very aware of that and this pattern has been going on for at least a hundred years if not more I mean really more Galileo uh went through exactly the same thing and you know I mean I I'm a huge admirer of Francis Collins but he stepped in it "
    },
    {
        "start": 9594.899,
        "text": "uh when he said somebody asked him what could you have done better in the pandemic he said I wish we knew where hesitancy comes from well every historian of Science and political scientist was you know what's that emoji whether you're going like this um with that because that kind of thing's been worked out for years but you know I didn't really know all that stuff when I was going through my education uh I didn't really even start thinking about that until I went into Administration or even even after uh and so we're really short changing the scientists that we're not preparing to understand you know and the Open Access things and other great thing uh because you know what happens people saying they're doing something Progressive that ends up harming the people who are marginalized I mean that's what this APC deal is elsevier is saying look we're open you "
    },
    {
        "start": 9655.979,
        "text": "know and meanwhile they're closing out people from publishing um and that's no different from redlining or you know a million other sociological things that that we've had in the world and the fact that that that scientists aren't uh required to have an appreciation for this uh I think is is hurting us and we need to correct that great morning hi um can you hear me yeah okay I'm a graduate student and Doctor Chennai and March and C slick lab and I have a recommendation and a very general question so a very naive recommendation for retraction papers perhaps can be it's a bit controversial as well that maybe hold the reviewers accountable as well like if you retract the papers the reviewers also sort of come up because they're supposed to be accountable for that paper as well I suggest a knife recommendation and um the question that I had was with "
    },
    {
        "start": 9716.819,
        "text": "regarding the idea of integration and moving forward with data so like Dr amoreen's presentation we see that different waves of bioinformatics coming up so there's micro there is single cell now so as you see single cell data and special transcriptomics are more or less I mean done in every lab right but there's a lot of microarray data that is untapped right and that could hold some potential into new discoveries but people are moving towards single cell and spatial transcriptomics so they're not really focusing on that so how can you or as scientists or something that or someone who can sort of influence media can um encourage researchers to tap into those resources which are right now and looked at or they're not as important right now I guess my reaction is the the research is funded in this uh R1 you know your one scale so there is very little "
    },
    {
        "start": 9778.64,
        "text": "add-on for integration margin to make it usable to make it overlappable with the next r01 so I guess that's really a decision not only for researchers but also for societies and government as Citizens to figure out how to make create that add-on and then on the app the the beginning of the game there is also cohort development right a lot of an edge now fund Discovery projects but not for a biobank here and research resource building so so we have like a sparsity of attention to the beginning of the game at the end of the game that's my comment maybe I so what you're saying is that Norms then you have better understanding then then you're saying that like microarray a lot of is is that data is uh I think technology developing more and more we can see more detail about the problem you're studying but I think also "
    },
    {
        "start": 9838.859,
        "text": "you can use this previous data to make good questions not to answer right there is a there is a project I am working with Dr woman as well as Dr Lee Hartwell we are thinking to create like a catalog not just to answer make questions good questions from existing data right but I've been living in technology right and if technology comes you have more detailed understanding of biological systems right but integrate both the previous data new data and and think mathematically to how to integrate Dr kratzler you have a question uh or really like your presentation but I really want to Matthias customer over here okay yeah and really want to hack back on one area where you failed we failed as a society we failed that during the pandemic we were not able to effectively counteract the misinformation and yes you are "
    },
    {
        "start": 9898.979,
        "text": "communicating to scientists but as you said reasonable understanding of scientific history this was all reasonably predictable and educating scientists early on aggressively how to counteract misinformation uh is a charge everyone in this room has as we are educating scientists and you know I'm also Physicians I also failed my patients with Idol of covet in my inpatient services and my outpatient services really learning how to counteract that and moving forward we are living and we are here to serve the society and we have to get our messages out and you as a not-for-profit entity have the credibility in that space more than anybody else and really what enforce and recommend that you work actively with the community you bring those papers forward into social scientists how to develop and support Technologies how to do that most more "
    },
    {
        "start": 9959.34,
        "text": "most effectively yeah so we've had a lot of pieces on this um you know I think that but I also think that um reaching the influencers who you know the church leaders the the family members the you know the because if somebody you know I always say to the people I grew up with who think who believe some of this stuff I mean I'm from Fayetteville North Carolina as as Gill said it's the biggest army town in America so I'm not in the political majority there um and uh you know I'm like okay do you believe me you've known for 50 years or some Jackass has got a podcast all right and the you know what they believe a jackass has got a podcast and so the only person who's gonna compete with that is their priest or their local "
    },
    {
        "start": 10021.02,
        "text": "politician or you know someone they know that they they trust and you know those people aren't reading science so you know that that's a that's a tricky challenge that I'm not sure I mean I want to work on it I've written many editorials about this and we published lots of perspectives and review articles about all of this stuff but um you know who covers our stuff the mainstream Outlets that that these folks aren't watching they're not reading the New York Times they're listening to NPR those are our and watching the NewsHour those are our big Outlets no but you have a critical multiplexer Multiplex in fact and yes you can reach people who can reach people and this is you know our society American Society of nephrology does that exactly we are charging our dialysis nurses to address these with people into dialysis units who are the mothers and "
    },
    {
        "start": 10082.34,
        "text": "daughters of the police in the churches this is a societal effort and you have the ability to serve and continue to serve as a multiplier there yeah and uh that's the only statement and sure I know you have been on that boat and I want to reinforce that journey to continue okay I couldn't agree more and you know all I can say is we're giving it all we got so I I've one uh question and uh or it's a question comment about this we I think we need to understand why a hundred percent of Brasilia uh the city of Brazilia is is vaccinated if when they are in the midst of uh Missing information from their leadership as well so you know so what is it about you know these different populations I think June actually hit on it it's a cultural thing uh that can the culture can overcome the um uh the the leadership and the disinformation so I think it's it's a very interesting uh uh uh confounding thing one more question and then we're "
    },
    {
        "start": 10143.18,
        "text": "going to let uh oh uh hi my name is Bailey Garb I'm a PhD student here in the department um my question really is directed at Dr Thorpe by I wonder so science cell nature these are without a doubt the most high impact journals um we have in our in the field in general um and I wonder how that creates sort of a bottleneck and almost limits Open Access so you know in order to make or in order to get into these journals you need to have extremely high extremely high impact paper which often takes a really long time you know this could be a culmination of three papers in a less high impact Journal um and that increases the amount of time that labs are holding on to data holding on to publishable Works in order to reach these high impact journals so how do you combat this in your attempt to be as "
    },
    {
        "start": 10205.16,
        "text": "open access as possible well you're absolutely right about that and um that's a major shift that will need to happen um and you know it's not so first of all uh I always tell audiences with students and you reminded me that I forgot today that if you send a bunch of papers to science in your career none of them get published you can still become the editor-in-chief okay um because I'm oh for career uh sending research papers to science myself um and you know I grew up as I said publishing in the uh journals of the American Chemical Society and I was happy when I got a paper into Jax and I'm proud of my Jax papers but I'm also proud of my papers that were in inorganic chemistry and Jay Fizz cam which is where I sent them if they "
    },
    {
        "start": 10265.7,
        "text": "didn't get into Jax and I made my career doing that uh I got tenure and I got promoted and I got grants and I was able to do everything I wanted to do so um you know the short answer which is kind of glib is you know people should send us stuff when they think that it's just so impact high impact that it's worth worth all the garbage that you said they have to do you're right about all that stuff um but in the you know in terms of of trying to change that um you know one thing is to really celebrate papers that don't get into our Journal um and you know we have six journals and one of them signs signaling which has an impact factor of six okay well we're proud of our science signaling papers you know there's some great stuff in there they're long mechanistic papers that explain how things really work and you know I'm constantly pumping up "
    },
    {
        "start": 10327.5,
        "text": "science signaling as much as I can and if you get a paper in science signaling you should be proud that's a that's a kick-ass Journal um and so our you know the the journals that I just named or the specialized journals in your field there's nothing wrong with with those papers and I'm proud of all my my papers in the specialized journals and I hope you will be too but you know what I tell folks that work for me we're trying to do is we're trying to fight we unfortunately we can't pay the bills if we don't find the papers that everybody wants so of course when Google won Casp we called up demos and tried to get the paper because that's going to get cited thousands of times and lots of people are going to click on it and it's great and we have to have that to pay the bills but we also want the papers that nobody knows about so um you know it's fun for me to come to the University of Michigan and give a talk "
    },
    {
        "start": 10388.7,
        "text": "because there's so much great science here and this is an amazing place but I've been to a lot of universities that science editors haven't gone to to say don't think that you know it's impossible that uh you've got something that we want and I was constantly sending my folks out to do the same thing and we got to try to break down a lot of this ossified gatekeeping that you're describing but it's not going to happen overnight because unfortunately you know one of the reasons why we have to have journals is because if we didn't the Deans and provosts of these universities wouldn't know who to promote they can't read all of this stuff themselves and decide uh if it's excellent science or not uh you know when I was a Provost I used to have this many tenure cases sitting on my desk in the spring and you know I just went and looked at the CVS what else I was going to do "
    },
    {
        "start": 10448.819,
        "text": "um and the giving grants and the whole and you all leaving and getting jobs I mean I hope your advisors are not going to let you go out in the job market with a list of preprints I mean if you're in computer science uh you can do that because the way they do their meetings and that's actually a very Progressive system but for those of you who are in the Life Sciences you know you can't do that my son's a graduate student I'm not going to let him graduate with a list of pre-prints on his CV and thankfully his advisor is not either he's not going to do that um so you know this whole system uh needs reform and um you know we got to give it all we got to try to change it and you know we have confidence in all of you to do that when you when you when uh even now but especially in the future well that's awesome thank you Holden very much for this um wonderful you know thanks for the panel for a great discussion and everyone now that's just "
    },
    {
        "start": 10510.26,
        "text": "a few little things first of all you know Gil how wonderful it is on this eighth Omen lecture that we got a policy discussion going which is something Martha it's something that we really wanted and it's worked out great it's the time to expand our minds Beyond just the narrow focus of the science of bioinformatics and competition medicine and bioinformatics and think about the big things and holding you've helped us do that in the eighth open lecture and we're really appreciative of that um thank you well and you know the whole day has been so great and we got more out there in the um all the posters and the refreshments and everything awaits us before we do that um this has been a great day for our department and for the medical school and the University and um it's it's um it's something that um uh depended upon a lot of people putting in a lot of hard work uh Teresa Nestor Elizabeth pamel you've seen Aaron and "
    },
    {
        "start": 10572.12,
        "text": "Paul and Ken around here the entire team our great staff team did so much and of course at the last minute Allah generously pulled together that wonderful session that was this morning with the students uh and Margaret was there and Katie and Julia helped I mean it's the big team it's that you you didn't see my talk but I ended with that same statement that you said Dan and so um and we talked about the future in the future lies and the students back there and Beyond into the screen and all their faculty and those posters um it's special because we're going to a special place it's called The Omen atrium and uh we're gonna go now visit the omen Atrium and enjoy our reception and the posters in having those conversations that we can't have on Zoom but we can have right here now thank you so much for everybody's attention and thank you so much uh Holden and all the speakers and guests "
    },
    {
        "start": 10634.52,
        "text": "and uh and Aaron what a job thanks everybody and let's go have some nice reception reception [Applause] [Music] "
    }
]